Part 11. The Fetus and Neonatal Infants
Part 11. The Fetus And The Neonatal Infant
Chap 78. Overview of mortality and morbidity
; neonatal mortality
- 1st 24hr of life ; °¡Àå ³ô´Ù.
- 1¼¼ÀÌÇÏ deathÀÇ *65%
; perinatal mortality
- deaths of fetuses and infants from the 20th wk of GA through the 28th day after birth
; infant mortality rate
- socioeconomic, cultural, geographic variables, prenatal care, nutrition, social support, risk identification, and obstetric care
; LBW´Â lethal congenital anomaly¿Í ´õºÒ¾î neonatal mortalityÀÇ Áß¿äÇÑ factor
- ¹Ì±¹¿¡¼´Â LBW rate°¡ 1981¿¡¼ 1991³â»çÀÌ 6.6%¿¡¼ 7.1% ·Î Áõ°¡
; premature birthÀÇ ¿øÀÎ
- amniotic fluid infection with GU tract bacteria, PROM, uterine abnormality, placental bleeding, multifetal gestation, drug misuse, maternal chronic illness, fetal distress, and maternal pyelonephritis
; postneonatl mortality
- deaths btw 28days and 1yr of life
; sudden infant death, infection, and trauma
- delayed neonatal mortality°¡ postneonatal mortalityÀÇ Áß¿äÇÑ ÀÎÀÚ
¡ÚTable
78-1 major causes of perinatal mortality
Chapter 79. The newborn infant
; Many of the newborn`s problems
- poor adaptation due to asphyxia, premature birth, life-threatening congenital anomaies, or adverse effects of delivery
79.1 History In Neonatal Pediatrics
1) identify disabling diseases that are amendable by prompt preventive action or treatment importance
2) anticipate conditions that may be of later importance
3) uncover possible causative factors that may explain pathologic conditions regardless of their immediate or future significance
# Inclusion
; demographic and social data , past medical illnesses in child and family, prior maternal reproductive problems, events occurring ih the present pregnancy, description of the labor, delivery
79.2 Physical examinations of the newborn infant
; initial examination Àº °¡±ÞÀû »¡¸® ½ÃÇàÇÑ´Ù.
General appearnace
; both active and passive muscle tone and any unusal posture should be recorded.
; coarse, tremulous movement with ankle or jaw myoclonus ; not pathologic
; ¡ØGeneralized Edema
- prematurity, hypoproteinemia secondary to severe erythroblastosis fetalis, nonimmune hydrops, congenital nephrosis, Hurler syndrome, or unknown cause
Skin
; Vasomotor instability and ciculatory sluggishness·Î ÀÎÇØ purple color¸¦ ¶é ¼ö ÀÖ´Ù. Âû¶§´Â acrocyanosis³ªÅ¸³¯ ¼ö ÀÖ´Ù.
; *harlequin
color change
- ¸Ó¸®¿¡¼ pubis±îÁö¸¦ ¿¬°áÇÑ ¼±À» Áß½ÉÀ¸·Î ¹ÝÀº red ¹ÝÀºpale color¸¦ ¶ì´Â °Í
; anemia
- erythroblastosis fetalis, subcapsular hematoma of the liver or spleen, subdural hemorrhae, or fetal-maternal or twin-twin transfusion
; mongolian spot
- slate blue, well-demarcated areas of pigmentationÀÌ buttock, back ¶Ç´Â ´Ù¸¥ ºÎÀ§
; skin of the premature infant
- gelatinous and bleeds and bruises easily lanugo hair
; skin of the postterm infant
- peeling, parchment-like skin
# *Erythema
Toxicum
- *»ýÈÄ 1-3ÀÏ¿¡ ³ªÅ¸³ª´Â vesiculopustular papule·Î 1ÁÖ±îÁöµµ Áö¼ÓµÇ¸ç ÁÖ·Î ¾ó±¼¿¡ ³ªÅ¸³ª³ª ´Ù¸¥ ºÎÀ§¿¡µµ »ý±æ ¼ö ÀÖ´Ù. eosinophilÀ» ÇÔÀ¯Çϰí ÀÖ´Ù.
; pustular melanosis
- ÁÖ·Î ÈæÀο¡ ¸¹À¸¸ç »ýÈÄ ¹Ù·Î ³ªÅ¸³ª´Â vesiculopustular eruptionÀ¸·Î neutrophilÀ» °®°í ÀÖ°í chin, neck, back, extremity¿Í palm or sole ¿¡ ³ªÅ¸³¯ ¼ö ÀÖ°í 2-3ÀϱîÁö Áö¼ÓµÉ ¼ö ÀÖ´Â benign lesion
; excessive skin fragility and extensability
- Elers-Danlos syndrome, Marfan syndrome, congenital contractural arachnodactyly
Skull
; suture line, the size and tension of the anterior and posterior fontanelleÀ» ¸¸Á®ºÁ¾ß ÇÑ´Ù.
# ¢¾Large
Fontanelle°ú ¿¬°üµÈ
Áúȯ
Table 79-1
; craniotabes
- parietal bone¿¡¼ sagittal suture±ÙóÀÇ vertex¿¡¼ ÀÖÀ» ¼ö ÀÖÀ¸³ª º´ÀûÀÎ °ÍÀº ¾Æ´Ô.
; soft areas in the occipital region
- osteogenesis imperfecta, cleidocranial dysostosis, lacunar skull, cretinism and Down syndrome
; megalencephaly
- hydrocephaly, storage disease, achondroplasia, cerebral gigantism, neurocutaneous syndrome, or inborn error of metabolism or familial
Face
; epicanthal folds, widely spaced eyes, microphthalmia, long philtrum, and low-set ear
- congenital syndrome
; asymmetry
- 7th n. palsy
-
*Symmetric Facial Palsy
/
¡ØMobius
syndrome
/ absence or hypoplasia of the 7th n. nucleus
Eyes
¡Ø97 labyrinthine and neck reflex
- spontaneous eye opening maneuver
- held up and tipped gently forward and backward
; *conjunctival
and retinal hemorrhageÀÚü´Â not significant
; ¡Ø½½ Leukocoria
- cataract, tumor, chorioretinitis, ROP, or a persistanthyperplastic primary vitreous and warrants an ophthalmologic consultation
Ears
; deformity of the pinae°¡ °¡²û º¸ÀÓ
; preauricular skin tag
Nose
; nare should be symmetric.
Mouth
; neonatal teeth
- normal
-
*Ellis-van Creveld,
Hallermann-Streiff, and other syndrome
- extraction ÇÊ¿ä¾øÀ½
; soft and hard palate - high arched palated, bifid uvula
; *Ebstein
pearls
- hard palateÀÇ raphe¾ç¿·¿¡ epithelial cellÀÇ temporary accumulation
; active salivation Àº ¾ø´Ù.
; relatively large tongue, short frenulum
; cheek - sucking pads
; throat
- palatal arch¶§¹®¿¡ º¸±â ÈûµéÁö¸¸ posterior palatal or uvular cleft¸¦ ³õÄ¡Áö ¾ÊÀ¸·Á¸é Àß °üÂûÇÏ¿©¾ß ÇÔ.
Neck
; Congenital torticollis
- ¸Ó¸®´Â º´º¯ÂÊÀ¸·Î face´Â º´º¯ ¹Ý´ëÂÊÀ¸·Î ±â¿ï¾îÁü.
Chest
; Asymmetry, erythema, induration, and tenderness
- breast abscess
; *Shield-shaped
chest - Turner syndrome
Lung
; usual rate : 30-40/min
- premature¿¡¼´Â more rapid and fluctuates more widely
- 60/minÀÌ»óÀ϶§´Â cardiac or pulmonary disease
; Cheyne-Stokes rhythm
- premature¿¡¼ ³ªÅ¸³¯ ¼ö ÀÖ´Ù.
; weak groaning, whinning cry, or grunting
- cardiopulmonarydisease
Heart
; normal - 90~180/min
; premature¿¡¼´Â sudden onset sinus bradycardia³ªÅ¸³¯ ¼ö ÀÖ´Ù.
; pulse - COAÁø´ÜÀ» À§ÇØ U/E, L/E¸¦ ´Ù palpationÇÏ¿©¾ß ÇÑ´Ù.
Blood pressure
; auscultatory method
; Doppler method
; palpatory method
; flush method
Abdomen
; liver °¡ ¸¸Á®Áú ¼ö ÀÖ´Ù. ( 2cm±îÁö)
; gas´Â »ýÈÄ 24½Ã°£¿¡ rectum ¿¡¼ º¸¿©¾ß ÇÑ´Ù.
; ¡Ø89 Cystic Abdominal Mass
- hydronephrosis, multicystic-dysplastic kidney, adrenal hemorrhage, hydrometrocolpos, intestinal duplication, choledochal, ovarian, omental or pancreatic cyst
; solid mass
- neuroblastoma, congenital mesoblastic nephroma, hepatoblastoma, and teratoma
; solid flank mass due to renal vein thrombosis
-hematuria, hypertension, and thrombocytopenia
- asso. with
/
*polycythemia, dehydration,
diabetic mothers, asphyxia, sepsis, and coagulopathies such as antithrombin III
or protein C deficiency
; Abdominal distension
- shortly after birth
: obstruction or perforation of GI tract, meconium ileus
- Later distension
: lower bowel obstruction, sepsis, or peritonitis
; Scaphoid abdomen - diaphragmatic hernia
; Abdominal wall defect
- omphalocele ( through the umbilicus )
- gastroschisis ( lateral to midline )
; ¢¾Omphaloceleµ¿¹ÝµÈ
񃀁
- Beckwith-wiedemann syndrome, conjoined twin, 18-trisomy, meningomyelocele, imperforate anus
Genitalia
; genitalia¿Í breast´Â maternal hormone¿µÇâÀ¸·Î ÀϽÃÀûÀ¸·Î Ä¿Áö°Å³ª discharge°¡ ÀÖÀ» ¼ö ÀÖÀ¸³ª observation
; imperforate hymen- hydrometrocolpos
; transitory hydrocele
; severe hypospadia, epispadia
- suspect abnormal sex chromosome
- e.g.) adrenogenital syndrome
; *»ýÈÄ 24½Ã°£ À̳»¿¡ voidingÇÏ¿©¾ß ÇÔ
Anus
; term infantÀÇ 99%, preterm infantÀÇ 95%°¡ 48½Ã°£ À̳»¿¡ meconium passage ÇÔ
; imperforate anus
Extremities
; polydactyly, syndactyly, abnormal dremoglyphic pattern
; hip evaluation; to R/O congenital dislocation
Neurologic examination
; Sx & Sg of fetal neuromuscular disease
- breech presentation, failure to breath at birth, pulmonary hypoplasia, dislocated hips, undescended testes, thin rib, clubfoot
Ordinary Care Of The Newborn Infant
# ¡ØBasic Requirements
1) establish respiration
2) adequate nutrition
3) maintain normal temperature
4) avoiding contact with infection
79.3 Routine Delivery Room Care
# Apgar score
;
low score°¡ ¹Ýµå½Ã
*fetal hypoxia¸¦ ÀǹÌÇÏ´Â
°ÍÀº ¾Æ´Ô
; *neonatal mortality³ª
cerebral palsy¸¦ ¿¹°ßÇÏ´Â
ÁöÇ¥µµ ¾Æ´Ô
; 1 min Apgar score
- need for immediate resuscitation
; 5-,10-,15-,20-min Apgar score
- probability of successfully resuscitating the infant
¡ÚTable
79-2
Maintenance Of Body Heat
; estimated heat loss°¡ ¡Ø89°´ adultÀÇ 4¹è
; usual delivery room temp.ÀÏ ¶§ skin temp. 0.3¡É/min, core temp. 0.1¡É/min °¨¼Ò
; heat loss
- by convection, conduction, radiation, evaporation
; cold exposed term infant
- metabolic acidosis, hypoxemia, hypoglycemia, increased renal excretion of water and solute
; ¡Ø89 Heat Production
- increasing the metabolic rate and oxygen consumption
- releasing norepinephrine --> fat oxidationÀ» ÅëÇÑ thermogenesis
- increased muscular activity
; °« ÅÂ¾î³ ¾Æ±â´Â ¹Ù·Î ´ÛÀÌ°í ´ã¿ä·Î °¨½Ñ´Ù.
Antiseptic Skin And Cord Care
; umbilical cord
- triple dye or bactericidal agents
; *chlorhexidine
washing or a single hexachlorphene bath
-
*repeated hexachlorpheneÀÇ total body exposure´Â
neurotoxic À̹ǷΠcontraindication
Other measures
The eyes
; 1% silver nitrate drops
-
*best proven therapy
; alternative 0.5% erythromycin and 1.0% tetracycline sterile ophthalmic ointment, povidone-iodine(*2.5% solution)
IM of 1 mg of water-soluble vitamin K1(phytonadione)
; ¡Ø91 large amount ½Ã hyperbilirubinemia, kernicterus
Neonatal Screening
; hypothyroidism, sicke cell anemia, phenylketonuria, homocystinuria, galactosemia, adrenogenital syndrome, cystic fibrosis, possible HIV infection, maple syrup urine disease, other organic or amino acidopathies
79.4 Nursery Care
; Infant`s temp
- óÀ½¿£ rectal ±×ÈÄ axilla·Î Àé´Ù.
- ù 2-3Àϰ£Àº 4½Ã°£ °£°Ý, ±×ÀÌÈÄ 8½Ã°£ °£°Ý
- axillary temp. 36.4-37.0`C
79.5 Parent-Infant Bonding
Nursery And Breast-Feeding
1) immediate postpartum mother-infant contact with suckling
2) rooming-in
3) demand feeding
4) inclusion of fathers in prenatal breast-feeding education
5) support from experienced women
Drug And Breast-Feeding
Table 79-4
# ¡ÚMedical
Contraindication
; HIV infection, primary CMV, hepatitis B virus(until receives HBIG & vaccine)
Chapter 80. High-Risk Pregnancies
¡ÚTable
80-1
¢ÞTable 80-2 maternal
disease affecting the fetus or neonate
¡ÚTable
80-3
Genetic Factors
; chromosomal abnormalities, congenital abnormalities, inborn errors of metabolism, mental retardation, or any familial disease in blood relatives
Maternal Factors
# age
# maternal illness; multiple pregnancy, infection, certain drugs
# polyhydramnios & oligohydramnios
¢Þ¡ÚTable
80-4 conditions associated with disorders of amniotic fluid volume
# amniotic fluid index
; vertical diameter of amniotic fluid pockets
; >24cm - polyhydramnios
; <5cm - oligohydramnios
# 2nd trimester maternal AFP
; elevation
- multifetal gestation, open neural tube defect, threatened abortion, hydrops with ascites, cystic hygroma, gastroschisis, omphalocele, congenital nephrosis, polycystic renal disease, epidermolysis bullosum, amniotic bands, ectopia cordis, placental hemangioma, retroplacental hemorrhage, Kell or Rh sensitization, matermal disease such as liver cancer, yalk sac tumor, viral hepatitis, and lupus anticoagulants
;
¡Úlow
- incorrect GA estimate, *trisomy 18 or 21, IUGR
# Uterus large for the estimated stage of gestation
; multiple fetuses, hyhydramnios, excessively large infant
Chapter 81. The fetus
81.1 Fetal Growth And Maturity
; biparietal diameter, head-to-abdomen circumference ratio, femoral length and total uterine volume measurement
¢ÞTable
81-1 Fetal Diagnosis And Assessment
¡Ø87ÁÖ Amniocentesis
¢¾Cordocentesis
81.2 Fetal Distress
# Indications For BPP
; intrauterine growth retardation, postdate gestation, maternal DM, Rh sensitized pregnancy, previous history of stillbirth, maternal hypertension
# ¡ÚContinuous
Fetal Heart Rate Monitoring
1) ¡Ø91 tachycardia ( >160/min)
; early fetal hypoxia, maternal fever, maternal hyperthyroidism, maternal ¥â-sympathomimetic or atropine therapy, fetal anemia, fetal arrhythmia
2) fetal bradycardia
; fetal hypoxia, placental transfer of local anesthetic agents and ¥â-adrenergic blocking agent, heart block with or without CHD
3) early deceleration
; head compression
4) variable deceleration
; cord compression
5) late deceleration
;
*fetal hypoxemia
Fig. 81-4
# Fetal Scalp Blood Sampling
*pH<7.25
; fetal distress
*pH<7.0
; indication for early delivery
81.3 Maternal Disease And The Fetus
# Infectious disease
miscarriage, stillbirth, or premature labor
# Noninfectious diseases
1) maternal DM
; organomegaly, hyperplasia of the ¥â cells of the fetal pancreas, metabolic derangement, intrauterine death
2) PIH, chronic hypertension, renal disease
; SGA, prematurity, intrauterine death
3) uncontrlled maternal hyperthyroidism or hypothyroidism
; infertility, abrtion, premature labor, fetal death
4) untreated maternal PKU
; miscarriage, congenital malformation, injury to the brain of the nonPKU fetus
81.4 Maternal Medication And The Fetus
¡ÚTable
81-3, 81-4
81.5 Identification Fo
Fetal Disease
# Indication
1) abortion is being considered
2) direct fetal treatment is possible
3) intrauterine fetal demise¸¦ ÇÇÇϱâÀ§ÇÑ °áÁ¤ÀÌ ÇÊ¿äÇÒ ¶§
4) high-risk pregnancy or high-risk fetusÀÇ history°¡ ÀÖÀ» ¶§
# Real time ultrasonography
# Amniocentesis
; Indication
- erythroblastosis fetalis, genetic indication, chromosomal abnormalities, neural tube defect, inborn metabolic errors, adrenogenital syndrome, thyroid dysfunction, lung maturation
;
¡Ø90
Index Of Pul. Maturation
- saturated phosphatidylcholine
- osmophilic bodies or phosphatidylglycerol
-
L/S ratio : *ˤ˂
µÎ°¡Áö°¡ more specific
# ¡Ø87 Early Lung Maturation
; premature separation of the placenta, premature rupture of the fetal membrane, narcotic addiction, maternal hypertensive and renal vascular disease
81.6 Treatment and Prevention of Fetal Disease
81.7 Teratogens
# Mechanisms Of Teratogenesis
1) cell death without reparative regeneration
2) mitotic delay
3) delayed differentiation
4) physical or vascular constraining
5) reduced histogenesis secondary to cell depletion, necrosis, calcification, or scarring
6) inflammation
1. Category A ; no risk based on evidence from controlled human trials
2. Category B ; either no risk from animal studies but no adequate studies in humans or some risk in animal studies that are not confirmed by human studies
3. Category C ; either definite risk from animal studies but no adequate human studies or no available data for animals or humans
4. Category D ; some risk but with a benefit that may exceed that risk for the treated life-threatening condition
5. *Category
X ; contraindicated in pregnancy based on animal and human evidence and whose
risk exceeds the benefits.
81.8 Radiation
; *maternal
exposureÀÇ limit : ÀӽŠ40ÁÖ µ¿¾È 500mrad
; *therapeutic
abortion : 10000mradÀÌ»ó ³ëÃâµÇ¾úÀ»
¶§
Chapter 82 The High-Risk Infant
# retroplacental hematoma
# placental edema
; fetofetal transfusion syndrome, hydrops fetalis, congenital nephrosis, or hepatic disease
# Amnion nodosum, oligohydramnios
; pulmonary hypoplasia, renal agenesis
# short cord, noncoiled cord
; chromosomal abnormality, omphalocele
# meconium stain
; asphyxia, pneumonia
# single umbilical artery
; congenital abnormality
# *GA 30Á̸ֹ¸°ú 1000g ¹Ì¸¸¿¡¼ °¡Àå neonatl mortality°¡ ³ô´Ù.
# 4000gÀÌ»ó, 42ÁÖÀ̻󿡼µµ ¸¶Âù°¡Áö·Î risk°¡ Áõ°¡ÇÑ´Ù.
¡ÚTable
82-1
82.1 Multiple pregnancies
Incidence
; highest among blacks & east indians
- lowest among the asians
; ovarian stimulants¿¡ ÀÇÇÑ infertility Ä¡·á·Î ÀÎÇØ ±× incidence°¡ Áõ°¡ÇÏ´Â Ãß¼¼
Etiology
; monovular twinÀº genetic factor¿Í ¹«°ü
; polyovular twin
-
*more frequent beyond 2nd preg.,
older women, family history(+)
; conjoined twin
- ´ëºÎºÐ ¿©¾Æ, ¼ö¼úÀÇ °¡´É¼º¿¡ µû¶ó ¿¹Èİ¡ ´Þ¶óÁø´Ù.
; prenatal diagnosis of twins
- large utrine size, 2 fetal heart tone, elevated maternal serum ¥á-FP or HCG, confirmed by USG
Monozygotic Versus Dizygotic Twins
1) comparison of physical characteristics, detailed blood typing, DNA fingerprinting or tissue typing
Placenta Examination
Problems Of The Twin Gestation
1) polyhydramnios, hyperemesis gravidarum, pre-eclampsia, prolonged rupture of membrane, vasa previa, velamentous insertion of the umbilical cord, abnormal presentation, and premature labor
2) *IUGR,
twin-twin transfusion, congenital anomalies
; monozygotic twin¿¡ ƯÈ÷ ¹®Á¦°¡ µÈ´Ù.
3) ¡ÚCongenital
Anomalies
; uterine compression deformity from crowding
- hip dislocation
; vascular communication with embolization
- ileal atresia, porencephaly, cutis aplasia
; vascular communication without embolization
- acardiac twin
; unknown factors that cause twinning
- conjoined twins, anencephaly, meningomyelocele
Placental Vascular Anatomoses
¡Ø97 Fetal Transfusion Syndrome
; monochorionic twin¿¡¼ ¹ß»ý
; Hb 5g/dl, Bwt. 20% ÀÌ»ó Â÷À̳².
; maternal hydromnios °¡ ÀÖÀ¸¸é ÀǽÉ
;
¡Ø92¦Áþ±â Table 82-2
;
*intrauterine death of one fetus
--> DIC of another fetus
; Tx
-
*maternal digoxin, selective twin
termination, Nd:YAG laser ablation of the anatomosis
Postnatal Identification
# Criteria for monovular twin
1) same sex
2) °Ñ¸ð½ÀÀÌ À¯»ç
3) hair colr, texture, natural curlµîÀÌ À¯»ç
4) eye color, shade°¡ À¯»ç
5) skin texture¿Í color°¡ À¯»ç
6) hands, feet´Â similar size
7) anthropometric value ; close agreement
Prognosis
# *neonatal
mortality´Â Â÷À̰¡
¾øÀ¸³ª perinatal mortality´Â 4¹è
# ¡Ø2nd baby´Â
anoxiaÀÇ À§ÇèÀÌ ´õ
¸¹´Ù.
; placenta separation after birth of first twin
; abnormal presentation
; decreased uterine tone
; close of cervix after birth of first twin
82.2 Prematurity And Intrauterine Growth Retardation
Definitions
# Prematurity ; WHOÁ¤ÀÇ»ó 37ÁÖ ÀÌÀü¿¡ Ãâ»ý
# LBW ; 2500gm less
# ELBW - less than 1000 g
Incidence
1) In USA, 30% fo LBW infant; IUGR
2) In developing country, 70% of LBW are IUGR.
VLBW infant
1) 50% of neonatal death, 50% of handicapped infant
2) survival ; 20% of 500-600g, 85-90% of those between 1250-1500g
Factor Related To Premature Birth And Low Birthweight
Table 82-3,4
# IUGR
; Á¦Å±Ⱓ¿¡¼ Ãâ»ý üÁßÀÌ 10 percentile ¹Ì¸¸ÀÎ °æ¿ì
; Ponderal index
-
*üÁß(gm)/Ű3(cm3)x100
-
*normal 2.32~2.85
; Symmtric
- earlier onset, chromosomal, genetic malformation, teratogenic, severe maternal hypertensive etiologies
; Asymmetric
- later onset, poor maternal nutrition or late onset or exacerbation of maternal vascular disease
¢¾Ç¥ 12-3
Assessment Of Gestational Age At Birth
; *neurologic
maturity´Â gestational age¿Í
»ó°ü°ü°è
; ¡Ø94ÁÖ ÇÑ±ÛÆÇ º¼
°Í
- p244~p249
Nursery Care
1) need for incubator care and heart rate and respiration monitoring
2) need for increased oxygen
3) need for special attention to the details of feeding
Incubator Care
1) neutral thermal environment
;
heat production minimal, infant`s core temp. within the normal range*(36.5-37¡É)
2) humidity; *40-60%
3)
administrating oxygen
Feeding
# NPO
; respiratory distress, hypoxia, circulatory insufficiency, excessive secretion, gagging, sepsis, CNS depression, immaturity, or signs of serious illness
# Gastrostomy feeding
;
*increase in mortalityÀ»
º¸À̹ǷΠƯº°ÇÑ surgical conditionÀ» Á¦¿ÜÇϰí´Â
±Ý±â
Initiation Of Feeding
# ¢¾Advantages
; reduce risk of hypoglycemia, dehydration, hyperbilirubinemia
# 1000gmÀÌÇϵµ °¡´É
; 1ml of 5% dextrose, 1/2 strength·Î ½ÃÀÛ
; ÇϷ絿¾È 2½Ã°£ °£°ÝÀ¸·Î 1/4 ¾¿ strength Áõ°¡½ÃÄÑ full-strength·Î ¸¸µçÈÄ ´ÙÀ½³¯ ºÎÅÍ 1ml¾¿ ¾çÀ»Áõ°¡
;
*20ml/kg/24hrÀÌ»óÀº
´Ã¸®¸é ¾ÈµÈ´Ù.
;
*150ml/kg/24hr±îÁö
ÀÏ´Ü µµ´ÞÇϸé, ¾çÀº ´Ã¸®Áö
¾Ê°í Ä®·Î¸®¸¦
´Ã¸°´Ù.
# ¡ØHigh protein intakeÀΰæ¿ì : > 4.5g/kg/24hr
; abnormal plasma aminograms
; elevations in blood urea nitrogen, ammonia, sodium conc.
; metabolic acidosis
; untoward effects on neurologic development
# ¢¾LBW°¡ Physiologic anemia°¡ ´õ
½ÉÇÑ ÀÌÀ¯
; smaller fetal iron stores
; greater expansion of blood volume due to rapid growth than term infant
; fetal or neonatal blood loss
# ¡ÚRequired
Vitamin
; vitamin C, D and other fat-soluble vitamin (Vit. E, Vit. K)
; folic acids
# Irion supplement
;
*VLBW infant¶óµµ
üÁßÀÌ µÎ¹è°¡
µÉ ¶§±îÁö´Â
º¸ÃæÇÒ Çʿ䰡
¾ø´Ù.
;
*Vitamin E deficiency risk°¡
ÀÖ´Â °æ¿ì¿¡´Â
º¸ÃæÇؼ´Â ¾ÈµÈ´Ù.
- hemolysisÀ» Á¶ÀåÇϰí, vitamin E Èí¼ö Àå¾Ö
;
*üÁßÀÌ
µÎ¹è°¡ µÇ¸é, Vitamin EÀ» Áß´ÜÇϰí, supplement (2mg/kg/24hr)
Fluid Requirements
TPN
# synthetic amino acid conc. ; 2.5-3 g/dl, hypertonic glucose; 10-25g/dl
# initial glucose
; 10-15g/kg/24hrs -> 25-30 g/kg/24hrs·Î Áõ·®
# intralipid
; 0.5 g/Kg/d·Î ½ÃÀÛ -> 3 g/Kg/d±îÁö Áõ·®
; 0.5 g/Kg/d¸¸À¸·Î essential fatty acid deficiency¸¦ ¿¹¹æÇÒ ¼ö ÀÖ´Ù.
# LBWÀÇ °æ¿ì TPNÀ¸·Î *100 Kcal/Kg/24hrs¸¦ À¯ÁöÇϸé 15 g/Kg/dÀÇ gain°¡´É
# ¡Ø91ÁÖ 1st
1wk peripheral TPN regimen
; 2.5 g/kg/d of amino acid
; 10 g/dl of glucose
; 2-3 g/Kg/d of intralipid
# ¡ÚLimited
Glucose Conc. Via pph Line
;
*12.5 g/dl
# IV supplimentation of tolerated oral feeding
; preterm¿¡¼ gavage feeding°ú º´ÇàÇÏ´Â °ÍÀÌ º¸Åë, À̶§ iv fluid´Â glucose, lipid, amino acid¸¦ ´Ù supplyÇÒ °Í
# ¡Ø89 Complication
1) related catheter
; sepsis
; thrombosis
; extravasation of fluid
; accidental dislodgment of catheter
; phlebitis, cutaneous sloughs, superficial infection
2)
metabolic complication
;
*hyperglycemia
-->
*osmotic diuresis, dehydration
;
azotemia
;
increased risk of nephrocalcinosis
;
hypoglycemia
;
hyperlipidemia & possible hypoxemia from IV lipid infusions
;
tissue accumulation of aluminum
;
hyperammonemia
;
cholestatic jaundice
;
hyperchloremic acidosis
; essential FA deficiency
Prevention Of Infection
; wash rigorouly hand to elbow before and after handling the infant
; *¡ãimportant factor in successful care of premature infant
- skill, experience, number of nursing staff
Immaturity Of Drug Metabolism
1) ´ëºÎºÐÀÇ ¾àÀÌ kidney excretion ÇϹǷΠintervalÀ» ´Ã·Á¾ß ÇÑ´Ù.
2) liver ´ë»çµÇ´Â ¾à¹°Àº smaller dose·Î.
Prognosis
¢¾Table
82-8
# *LBW
infant°¡ term infant¿Í physical growth°¡ °°¾ÆÁö´Â
½Ã±â
; 2nd yr
# Overall Incidence Of Neurologic And Developmental Handicap In VLBW
;
*10-20%
- cerbral palsy (3-6%)
- moderate to severehearing and visual defect(1-4%),
- learning difficulty(20%)
Predicting Neonatal Mortality
# Survival
; *22wk(0%), 23wk(15%), 24wk(56%), 25wk(79%)
# Birthweight-Speicific Neonatal Disease
;
*Grade IV IVH, severe GBS
pneumonia, pulmonary hypoplasia
# Index for neonatal mortality
CRIB ( Clinical Risk Index for Babies)
SNAP( Score for Neonatal Acute Physiology)
Discharge From Hospital
# ¢¾Criteria
; all nutrition by nipple, either bottle or breast
; steady increment growth; 10-30 g/day
; open crib¿¡¼ ¾ÈÁ¤Àû ü¿ÂÀ¯Áö
; no recent apnea or bradycardia
; parenteral drug should be discontinued
; 1800-2100gm
# oxygen therapy
; eye exam. for ROP
# All LBW ; hearing test
# umbilical catheter ; BP check for renal vascular hypertension detect
# Hb check; anemia detect
82.3 Post-Term Infants
; after 42wk of gestation
¡Ø87 Clinical Manifestations
; absence of lanugo, decreased or absent vernix caseosa, long nails, abundant scalp hair, white parchment-like or desquamating skin, increased alertness
Prognosis
; *delivery
3wkÀÌ»ó delayµÇ¾úÀ»
¶§ 3¹èÀÌ»ó mortality°¡ ³ô´Ù.
Treatment
; careful obstetric monitoring
; 2-4wkÀÌ»óµÇ°í ³ë»ê, fetal distress³ªÅ¸³¯ ¶§´Â labor inductionÀ̳ª C-sec
82.4 Large for
gestational age
# *Predisposing
factor
; maternal DM, obesity
# ¡Ø°´ Higher Incidence of
; birth injury
- cervical & brachial plexus injuries, phrenic nerve damage, fractured clavicles, cephalhematomas, subdural hematomas, ecchymoses of head & face
; congenital anomaly
- congenital heart disease
; intellectual & developmental retardation
CHAP 83. Clinical Manifestations of Diseases in The Newborn Period
Central Cyanosis
¡ÚTable
83-1 Differential Diagnosis of neonatal cyanosis
; respiratory insufficiency
- rapid, retraction of the thoracic cage
; CNS depression
- irregular, weak often slow respiration
; CHD or methemoglobinemia
- persisting cyanosis for several days without respiratory difficulty
Pallor
; acute hemorrhage, anemia, hypoxia, hypoglycemia, sepsis, *shock, *adrenal failure
Convulsion
; hypoxic-ischemic encephalopathy(from the asphyxia), ICH, cerebral anomaly, subdural effusion, meningitis, hypocalcemia, hypoglycemia, infarction, pyridoxine deficiency, hyponatremia, hypernatremia, inborn error of metabolism, drug withdrawal, familial seizure
; seizure in delivery room
- unintentional injection of matenal local anesthetic into fetus
- large amounts of hypotonic fluids to mother
--> hyponatremia
¡Ø Jitteriness
; normal newborns, DM mothers, birth asphyxia, drug withdrawal, polycythemic neonates
¡Ø87 96 DDx from convulsion
- resembling tremor
- stopped by holding the infant¡¯s extremities
- depend on sesory stimuli
- not asso. with abnormal eye movements
|
Jitteriness |
Seizures |
Abnormal gaze or eye movement |
- |
+ |
Response to sensory stimuli |
+ |
- |
Predominant movement |
Tremor |
Tonic clonic |
Stopped by passive flexion |
+ |
- |
Abnormal EEG |
- |
+ or - |
; seizures in premature
- often subtle
- asso. with abnormal eye or facial movements
- tonic
- *only apnea as 1st manifestation
; seizures in term
- focal or multifocal
- clonic or myoclonic
- more subtle
Motor automatism
; *oral-buccal-lingual
movement, rotatory limb activity(rowing, pedaling, swimming), tonic posturing
or myoclonus
; following severe motor asphyxia
; no accompanied EEG discharge
; poor response to anticonvulsant
; poor prognostic factor
Lethargy
; infection, asphyxia, hypoglycemia, hypercabnia, sedation from maternal analgesia or anesthesia, cerebral defect
¡Ú; after 2nd day --> infection
Irritability
; intraabdominal condition, meningeal irritation, drug withdrawal, infection, congenital glaucoma
¡Ø82°´Hyperactivity
; hypoxia, pneumothorax, emphysema,
hypoglycemia, hypocalcemia, CNS damage, drug withdrawal, *thyrotoxicosis, discomfort from the cold temp.
Failure to feed well
; most sick newborn
Fever
; *high
environmental temp., overheated nurseries or incubators
-
*¡ãcommon
; dehydration fever, serious infection
Fall in body temperature
; infection, other serious disturbances
Apnea
Jaundice during the 1st 24hrs
; erythroblastosis fetalis, septicemia, cytomegalic inclusion disease, congenital rubellar syndrome, toxoplasmosis
Jaundice after the 1st 24hrs
; septicemia, hemolytic anemia, galactosemia, hepatitis, congenital atresia, inspissated bile syndrome following erythroblstosis fetalis, syphillis, herpes simplex
Vomiting
; 1st day of life
- UGI obstruction, IICP
; septicemia, overfeeding, inexperienced feeding technique, pyloric stenosis, milk allergy, duodenal ulcer, stress ulcer, adrenal insufficiency
Diarrhea
; overfeeding, AGE, malabsorption, infection
; mesenteric thrombosis, necrotizing enterocolitis, strangulated hernia, intussusception, torsion of ovary or testis
Abdominal distension
; intraabdominal mass, intestinal obstruction, enteritis, NEC, ileus accompanying sepsis, respiratory distress, hypokalemia
Failure to move an extremity
Chapter 84. Birth Injury
; not include amniocentesis, intrauterine trasfusion, scalp blood sampling, resuscitation procedures
¡Ø82ÁÖ Predisposing factors
- macrosomia
- prematurity
- cephalopelvic disproportion
- dystocia
- prolonged labor
- breech presentation
84.1 Cranial Injuries
Caput succedaneum
; diffuse, ecchymotic, edematous swelling of soft tissues of the scalp
; across midline and suture line
; *disappear
within 1st few days
; no specific treatment
- phototherapy for hyperbilirubinemia due to extensive ecchymoses
; asso. with molding
Erythema, abrasion, ecchymoses and subcutaneous fat
necrosis
Subconjunctival and retinal hemorrhage
Petechiae
Cephalhematoma
; *subperiosteal
hemorrhage
; *always
limited 1 craial bone
; *no
discoloration of the overlying scalp
; *no
visible swelling until several hours after birth
; underlying skull fracture - linear not depressed
; *resorbed within 2wk-3mo but remain bony protubercephalohematoma as diploic space widening, cystlike defects for years
; calcify by the end of 2nd wk
; sensation of central depression --> not indication of underlying fracture or bony defect
; no treatment - contraindication for I & D
¡Ø Cranial meningocele
; pulsation
; increased pressure on crying
; X-ray evidence of bony defect
Fracture of the skull
; linear fracture
-
*¡ãcommon
- no treatment
84.2
Intracranial(Intraventricular) Hemorrhage
Etiology And Epidemiology
; trauma or asphyxia
- rarely in primary hemorrhagic disturbance or congenital vascular anomaly
- maybe in DIC, isoimmune thrombocytopenia, neonatal vitamin K deficiency
; massive subdural hemorrhage
- more often in full-term than in preterm infant
; *intraventricular
hemorrhage
-
*premature infants spontaneously
Pathogenesis of intraventricular hemorrhage
¢Þ
Gelatinous Subependymal Germinal Matrix
; embryonal neurons & fetal glial cells
; immature highly vascular area
; poor vascular support
-->
*predispose the premature infant
# ¡ÚPredisposing
Factor
; prematurity, RDS, hypoxic ischemic encephalopathy, reperfusion of damaged vessel, increased or decreased cerebral blood flow, reduced vascular integrity, increased venous pressure, pneumothorax, hypervolemia, hypertension
# periventricular leukomalacia
; hypoxic-ischemic-hypotensive injury·Î ¹ß»ý
; with or without severe IVH
; necrosis of the periventricular white matter and damage to the corticospinal fibers in the internal capsule.
Clinical manifestations
; *60-70%
of 500-750 g, 10-20% of 1000-1500 g
; *rarely
present at birth but 80-90% within 3rd days
- delayed hemorrhage after 1wk in 10-15%
; *new
onset IVH´Â 1°³¿ùÀÌÈÄ¿¡´Â
¸ö¹«°Ô¿¡ °ü°è¾øÀÌ
µå¹°´Ù.
; *diminished
or absent moro reflex, poor muscle tone, lethargy, apnea, somnolence
-
*¡ãcommon Sx
; *precipitous
deterioration on 2nd or 3rd day in premature infants
- apnea, pallor, or cyanosis, failure to suck well, abnormal eye signs, a high pitched shrill cry, muscular twitchings, convulsion, decreased muscle tone, paralyses, metabolic acidosis, shock, and a decreased hematocrit or its failure to increase after transfusion
; tense bulging fontanelle
; PVL
- usually asymptomatic till later infancy
-
*usually onset later as early echo
dense phase (3-10 days), followed by echo-lucent(Cystic) phase(14-20 days)
Diagnosis
# Real Time USG
;
*1000 gÀÌÇÏ infant
-
*1st 3-5 days and following wk
# ¢¾IVH
Grades
; Grade I
- bleeding confined to the germinal matrix-subependymal region or to less than 10% filling the ventricle
; Grade II
- IVH with 10-50% filling the ventricle
; Grade III
- more than 50% involvement with dilated ventricles
; Grade IV
- Grade III with corticoperiventricular intraparenchymal lesion
# IVHÀÇ 75%´Â grade I-II
# immaturity, severity of RDS ¿Í ¿¬°ü
- severe RDS¿¡¼ risk°¡ ´õ ³ô´Ù.
# CSF tapping
; signs of increased intracranial pressure or SAHÀÇ½ÉµÉ ¶§, bacterial meningitisÀÇ½ÉµÉ ¶§
# ¼Ò¼öÀÇ RBC³ª xanthochromia´Â intracranial hemorrhage°¡ ¾Æ´Ô
Prognosis
; *most
not develop posthemorrhagic hydrocephalus
- 10-15% of LBW have hydrocephalus
; Posthemorrhagic hydrocephalus
-
*regress or arrested in 65% of
affected infants
; ¢¾Poor
Prognosis
1) GA less than 30wk
2) prolonged mechanical ventilation (>28 days)
3) intrapernchymal hemorrhage
4) extensive PVL
5) progressive hydrocephalus required VP shunt
; *intraparenchymal
echo-densities greater than 1cm
-
*high mortality, high incidence of
motor and cognitive deficit
Prevention
; management of CPD & operative delivery
; maternal Tx with steroids, IV immnunoglobulin
; fetal transfusion
; *neonatal
administration of low-dose indomethacin & vitamin E
; *vitamin
K
-
*Pb or phenytoinÄ¡·á¸¦
¹Þ´Â »ê¸ð´Â
Ãâ»êÀü ¹Ýµå½Ã
¸Â¾Æ¾ß ÇÑ´Ù.
Treatment
; seizure - anticonvulsant
; anemia-shock
- PRC transfusion or FFP
; acidosis
- 1-2 mEq/Kg NaHCO3
; neurosurgical placement of the external ventriculostomy catheter in early stage of uncontrolled symptomatic hydrocephalus
84.3 Spine and Spinal
Cord
; *4th
cervical vertebra
- cephalic presentation
; *lower
cervical-upper thoracic vertebra
- breech presentation
84.4 Peripheral Nerve
Injuries
Brachial Palsy
Erb-Duchenne paralysis
; ¡Ø5th and 6th cevical nerves
; adduction and internal rotation of the arm with pronation of the forearm
; moro reflex absent on affected side
; sensory impairment on outer aspect of the arm
; forearm power & hand grasp preserved
Klumpke paralysis; rarer form
; ¡Ø85 7th and 8th cervical nerves and 1st thoracic nerve
; paralyzed hand
; *ipsilateral
ptosis and miosis (Horner syndrome)
Differential Diagnosis
; cerbral injury, fracture, dislocation, epiphyseal separation of the humerus
Prognosis
; involvement of deltoid
-
*¡ãserious problem
; upper arm paralysis°¡ better prognosis
Treatment
; partial immobilization and appropriate positioning
; ¢¾in
upper arm paralysis
- abduction 90¢ª
- full supination of forearm
- slight extension at wrist with palm turned toward face
; ¢¾in
lower arm paralysis
- padding in the fist
; immobilization
-
*intermittent while infant asleep,
between feedings
- brace or splint during the 1st 1-2wk
; in entire arm paralysis
- same treatment
-
*gentle massage and motion by
7-10days
; *if no
improvement for 3-6mo
-
*neuroplasty, neurolysis,
end-to-end anastomosis, nerve grafting
Phrenic Nerve Paralysis
; *3th,
4th, 5th cervical nerve
; Diagnosis
- U/S or fluoroscopic exam
- elevation of the diaphragm on paralyzed side
; recovery spontaneously by 1-3 mo
Facial Nerve Paralysis
; *compression
of facial nerve in utero
- from labor or forceps
; nuclear agenesis of facial nerve
; affected side
- forehead smooth, eye closure impossible, nasolabial fold absent, the corner of the mouth droops
84.5 Viscera
# Liver
; brain ´ÙÀ½À¸·Î ÀÚÁÖ injury¹Þ´Â organ
; contributing factors
- large infant, intrauterine asphyxia, coagulation disorder, extreme prematurity, hepatomegaly
; Laceration - surgical repair
# Rupture of spleen
# Adrenal Hemorrhage
; ¡ÚCauses
- breech delivery in LGA or infant of DM mother
- trauma, anoxia, severe stress, infection
;
*90% unilateral, 75% Rt. side
84.6 Fracture
Clavicle
1) affected side arm movement ¾øÀ½
2) absent moro reflex on affected side
3) spasm of the SCM with obliteration of the supraclavicular depression
4) prognosis ; excellent
Extremities
1) affected side; ¸ø ¿òÁ÷À̸ç moro reflex¾øÀ½
2) prognosis ; good
3) preterm infant; osteopenia
4) dislocation and epiphyseal separation
# nose ; dislocation of the cartilaginous portion of the septum
84.7 Hypoxia-ischemia
# Hypoxia
; arterial O2 less than normal
# Ischemia
; cell or organÀ¸·Î Á¤»ó±â´ÉÀ» ÇÒ ¸¸ÅÀÇ ÃæºÐÇÑ Ç÷¾×°ø±ÞÀÌ ¾ÈµÊ
¡ØEtiology
Fetal Hypoxia
1) inadequate oxygenation of maternal blood
; hypoventilation during anesthesia, cyanotic heart disease, respiratory failure, CO poisoning
2) low maternal BP
3) inadequate relaxation of uterus
4) premature separation of placenta
5) compression or knotting of the cord
6) placental insufficiency
7) uterine vessel vasoconstriction by cocaine
After Birth
1) anemia
2) shock
3) deficit in arterial oxygen saturation resulting from failure to thrieve
; due to cerebral defect, narcosis, or injury
4) failure of oxygenation of an adequate amount of blood
; due to cyanotic CHD or deficient pulmonary function
Pathophysiology And Pathology
# *Bradycardia,
Hypotension, Decreased Cardiac Output, Severe Metabolic & Respiratory Acidosis
; onset within minutes
--> increased shunting through ductus venosus, ductus arteriosus, foramen ovale
- initial circultory response
# Pathology of hypoxia-ischemia
; early congestion, fluid leak from increased capillary permeability, endothelial cell swelling
--> coagulation necrosis, cell death
; congestion & petechiae in pericardium, pleura, thymus, heart, adrenals, meninges
# Prolonged Intrauterine Hypoxia
; result in PVL & pulmonary arteriole smooth muscle hyperplasia
# chronic fetal asphyxia & acute hypoxic ischemic injury
-->
¢¾Gestational Age-Specific Neuropathology
; Term
-
*neuronal necrosis of the
cortex(later cortical atrophy) & parasagittal ischemic injury
- focal or multifocal cortical infarts
--> focal seizures or hemiplegia
; Preterm
-
*PVL(later spastic diplegia),
status marmoratus of basal ganglia, IVH
# *excitory
amino acids°¡ asphyxial brain injury¿¡
Áß¿äÇÑ ¿ªÇÒÀ»
ÇÑ´Ù.
Clinical Manifestations
# Sg Of Fetal Hypoxia
; IUGR with increased vascular resistance
; FHR monitoring
- bradycardia
- loss of beat-to-beat variability
- variable or late deceleration
; fetal scalp blood
- less than 7.20
# At Delivery
; meconium stained amniotic fluid
; depressed & fail to breathe
; hypotonia or change from hypotonia to extreme hypertonia
; pallor, cyanosis, slow heart rate, unresponsiveness to stimulation
--> cerebral edema during next 24hr
--> brain stem depression, seizure attack
¡ÚTable
84-1
Prognosis
# ¢¾Outcome
Depends On
1) metabolic and cardiopulmonary complicationÀÇ Ä¡·á¿©ºÎ
2) gestational age
3) severity of the hypoxic-ischemic encephalopathy
# ¢¾Death
Or Severe Cognitive & Motor Deficits Predictors
; low 20min Apgar score
; absence of spontaneous respiration at 20min of age
; persistence of abnormal neurologic signs at 2wk of age
# ¡Ø93ÁÖ
Brain Death
; unresponsive to pain, auditory, or visual stimulation
; apnea with Pco2 rising from 40 to over 60mmHg
; absent brain stem reflex(pupil, oculocephalic, oculovestibular, corneal, gag, sucking)
--> above 3 findings occur in absence of hypothermia, hypotension, elevated levels of depressant drugs
& inconsistently absence of cerebral blood flow on radionuclide scan & electrical acitivity on EEG
& above 3 findings persistence for 2 days in term & 3 days in preterm
Chapter 85. Delivery Room Emergencies
# *¡ãcommon & important emergency in delivery room
; failure to initiate and maintain respirations
Respiratory Distress And Failure
; airway obstruction and of depression of CNS
# *Choanal
Atresia, Bilateral
;
*respiratory movements with mouth
closed
--> but fail to move air in and out of lung
# hypoplasia of the mandible
# diaphragmatic hernia
Failure To Initiate Or Sustain Respiration
1) pulmonary hypoplasia associated with potter syndrome
2) severe organized intrauterine pneumonia
3) narcosis
treatment; initial physical stimulation and securing patent airway
¡Ø86,87 Resuscitation
# Goal
; prevent morbidity and mortality
; re-establish adequate spontaneous respiration and C.O
# successful respiration
; good chest rise, symmetric breath sound, improved pink color, HR greater than 100/min, spontaneous repiration, improved tone
# medication
;
¡Ø94
Indication
- HR < 80/min following 30 sec of combined ventilation & chest compression
or during asystole
; epinephrine
-
*0.1-0.3 ml/Kg of 1:10,000
solution, IV or intratracheal
- repeated every 5 min
- if no response
/ 5 to 10 times
; 10-20ml/Kg of volume expander
- N/S, blood, 5% albumin, Ringer`s lactate
; sodium bicarbonate
- 1-2mEq/kg, 0.5mEq/ml of 4.2% solution
- 1mEq/kg/min
- effective ventilationÈÄ¿¡ ÁØ´Ù.
; Dopamine(5-20 ¥ìg/Kg/min)
- poor peripheral perfusion, weal pulses, hypotension, tachycardia, poor U.O
Shock
1) cyanosis, pallor, flaccidity, cold mottled skin, tachycardia or bradycardia, hepatsplenomegaly, convulsion
2) treatment; Rh- O blood, plasma or electrolyte solution
Chapter 86. Dysmorphology
# Two Structural Defects
; single primary defect & multiple malformation syndrome
# ¢¾Seven
Most Common Single Primary Defect In Development
1. CDH
2. Talipes equinovarus
3. cleft lip with or without cleft palate
4. cleft palate alone
5. cardiac septal defect
6. pyloric stenosis
7. neural tube defect
# *next
babyÀÇ risk ; 2-5%
# multiple malformation syndrome
; due to chromosomal abnormality, single gene defect inherited in menelian pattern
Ç¥12-8, 12-9(p266-267)
Single Primary Defects In Development
Malformation
; *primary
structural defect arising from localized error in morphogenesis
; e.g.) *cleft
lip, congenital septal defect, pyloric stenosis
; multifactorial recurrence risk factors
- 2-5%
; excellent prognosis after surgical correction
Deformation
; *alteration
in shape or structure of a part that has differentiated normally
; mostly involve musculoskeletal system & caused by intrauterine molding
; intrinsically derived positional deformation
-->
*myotonic muscular dystrophy,
Wernig-Hoffmann disease
; extrinsically derived deformation of prenatal onset
--> fetal crowding
; other extrinsic factor
- breech presentation, shape of amniotic cavity
; e.g.) *talipes
equinovarus, congenital hip dislocation
-
*ˤ
µÎ°¡Áö¸¦ Á¦¿ÜÇϰí´Â
´ëºÎºÐÀÌ ºñ
À¯ÀüÀû ¿äÀÎ
-
*Àç¹ßÀ²ÀÌ
¸Å¿ì ³·°í, ¿¹ÈÄ´Â ¸Å¿ì
¾çÈ£ÇÏ¿© ÀÚ¿¬ÀûÀ¸·Î
±³Á¤µÇ´Â ¼ö°¡
¸¹´Ù.
Disruption
; *structural
defect resulting from destruction of previously normally formed part
# ¢¾Two
Basic Mechanism
1) entanglement followed by tearing apart or amputation of normally developed structure
- digit, arm, leg
2) interruption of blood supply to a developing part
- infarction, necrosis, resorption of structures
# Example
;
*nonduodenal intestinal atresia,
gastroschisis, porencephaly
# *genetic
factor ´Â ÁÖ¿ªÇÒÀ»
´ã´çÇÏÁö ¾Ê´Â´Ù.
Sequence
; *single
primary defect in early morphogenesis°¡
cascading process·Î multiple abnormalitiesÀ»
»ý¼ºÇÏ´Â Çϰųª tertiary errors in morphogenesisÀ»
ÀÏÀ¸Å°´Â °Í
# ¢¾Robin
Malformation Sequence
; single prenatal onset defect in development, mandibular hypoplasia
--> glossoptosis, blocking closure of the post. palatal shelves causing U-shaped cleft palate
# breech deformation sequence
; compression of developing fetal parts
--> bathrocephaly, torticollis, facial asymmetry, dislocated hip, valgus anomalies of both feet
# amniotic band disruption sequence
; constriction caused by entanglement in multiple fibrous strands of amnion extending from plcental insertion of umbilical cord to surface of amnion-denuded chorion or floating withiin chorionic sac
--> craniofacial and limb defects
Multiple Malformation Syndrome
1) chromosomal and genetic abnormalities by teratogens
2) intrauterine infection
; SGA, developmentally delayed, microcephaly or hydrocephalus, microphalmia, chorioretinitis, cataract, glaucoma, hepatosplenomegaly, thrombocytopenia
3) Williams syndrome
;
*deletion of one elastin allele
located within 7q11.23
4) Rubinstein-Taybi syndrome
;
*microdeletion in 16p13.3
5) Prader-Willi syndrome
;
*deletion involving 15q11-12,
paternal
6) Brachmann-de Lange syndrome
;
*single gene transmitted as an AD
7) VATER association
;
*vertebral defect, anal atresia,
tracheoesophageal fistula with atresia, radial upper limb hypoplasia, renal
defect
# evaluation ÇÏ´Â ¸ñÀû
(1) making specific overall diagnosis
(2) accurate prognostication about the child`s future development
(3) appropriate recurrence risk counseling for the parents
(4) appropriate plan to help the child reach his or her potential
Chapter 87. Respiratory Tract Disorders
87.1 Transition to Pulmonary Respiration
The First Breath
# Need pressure
;
*10-50cm of H2O for 0.5
to 1.0 sec-interval
;
*¾à 50ml°¡ Æó·Î
µé¾î°¡ 20-30ml´Â FRC°¡ µÈ´Ù.
# Removal of the liquid of the lung
;
*most - pulmonary circulation
, others - pulmonary lymphatics, expelled by the infant, swallowed, or aspirated from the oropharynx
; impaired removal
- C-sec, endothelial cell damage, neonatal sedation
# ¡ØStimuli of first breath
; fall in PO2 and pH
; rise in PCO2
; redistribution of CO after umbilical clamping
; decrease in BT
; variety of tactile stimuli
# ¢¾LBW
infant ÀÇ Æ¯Â¡
; very compliant chest wall --> disadvantage in first breath
; least FRC --> atelectasis
; greater and persistent abnormalities in ventilation-perfusion ratio
# low PaO2(50-60mmHg), elevated PaCO2
; reflecting atelectasis, intrapulmonry shunting, hypoventilation
Breathing Pattern In Newborns
# periodic breathing
; more common in the premature infant
; shifting from regular rhythmicity to cyclic brief episodes of intermittent apnea
;
*apneic pauses of 5-10sec followed
by burst of rapid respiration at a rate of 50-60/min for 10-15sec
; no change in color or heart
rate
; usually till premature infant
are about 36wks
; *no prognostic significance
87.2 Apnea
Causes
¡Ø91
Table 87-1 Potential causes of neonatal apnea and bradycardia
# Mechanism
1) depression of the CNS control of respiration
; hypoglycemia, meningitis, drugs, hemorrhage
2) disturbances of oxygen delivery by perfusion
; shock, sepsis, anemia
3) ventilation defects
; pneumonia, HMD, persistence of fetal circulation, muscle weakness
# Idiopathic apnea of prematurity
; absence of identifiable predisposing diseases
; type
- obstructive type
/ upper airway obstruction
/ pharyngeal instability, neck flexion, nasal occlusion
/ absent air flow but persistent chest wall movement
- central type
/ decrease of gestational age dependent reduced CNS stimulus
/ immaturity of brain stem
/ attenuated response to carbon dioxide & paradoxical response to hypoxia
- mixed type
/
*¡ãcommon
/ obstructive apnea following central apnea
# short apnea
; ÁÖ·Î central
; 15secÀÌ»óÀ̸é more mixed
# *sleep
state dependent
;
*REM sleep¿¡¼
¸¹´Ù.
Clinical Manifestations
; cessation of breathing for longer than 15-20sec or any duration if accompanied by cyanosis and bradycardia
; *idiopathic
apnea´Â »ýÈÄ 1ÀÏ¿¡´Â µå¹°±â¶§¹®¿¡
´Ù¸¥ ¿øÀÎÀ»
¸ÕÀú »ý°¢Çؾß
ÇÑ´Ù.
; 2nd-7th day onset
; ¡Ø91 »ýÈÄ 2ÁÖÈÄ¿¡ sudden onset apnea´Â critical eventÀ̹ǷΠÁï½Ã evaluationÇØ¾ß
ÇÑ´Ù.
; longer apnea(>20sec)Àϼö·Ï bradycardiaµ¿¹Ý
- 95%
Treatment
; *gentle
cutaneous stimulation
- adequate therapy for mild and intermittent episodes
; bag and mask ventilation
- recurrent prolonged apnea
; oxygen
; Drug therapy
-
*precipitating identifiable cause°¡
¾ø´Â °æ¿ì¿¡
»ç¿ë
- enhance central mechanism or improving iaphragmatic strength
-
*methylxanthine
/ loading 5mg/Kg, 1-2 mg/Kg every 8-12 hr using oral or IV
- caffein
/ loading 10mg/kg, 2.5mg/kg/24hr
; transfusion of packed red blood cells
; nasal CPAP(3-5cmH2O)
Prognosis
; *associated
problemÀÌ ¿¹Èĸ¦
°áÁ¤
- IVH, bronchopulmonary dysplasia, retinopathy of prematurity
; *apnea
of prematurity´Â 36wk postconceptional
age¿¡ È£ÀüµÈ´Ù.
;
*not predict furture episodes of SIDS
87.3 Hyaline Membrane Disease
Incidence
; *inversely
proportional to gestational age & birth weight
; *60-80%
of less than 28wk
- *15-30% of 32-36wk
- *5% beyond 37wk
# ¡Ø81,87 Predisposing Factors
; maternal DM, delivery before 37wk gestaion, multifetal pregnancy, C/S delivery, precipitous delivery, asphyxia, cold stress, Hx of prior affected infants
Etiology And Pathophysiology
¢ÀFig.
87-1 Composition Of Surfactant
; *high
surface tension and absence of surfactant
--> correlate with failure of FRC & tendency of atelectasis
; mature level of surfactant
-
*usually present after 35wk
¢ÞFig.
87-3
# ¡Ø92 Suppressive Factors Of Surfactant Synthesis
; asphyxia, hypoxemia, pulmonary ischemia, hypovolemia, hypotension, cold stress
; *ÃÖÁ¾ mechanism : atelectasis
- alveolar atelectasis, hyaline membrane formation, interstitial edema
--> less complaint lung
--> greater pressure
--> limiting intrathoracic pressure
--> volume of thorax & lungs approach residual volume
--> atelectasis
; highly complaint chest wall of preterm infant
- less resistance against collapse
- atelectasis¸¦ Á¶Àå
Patholgy
# gross; purplish red and liver like consistency
# microscopic finding
; extensive atelectasis, engorgement of intraalveolar capillaries and lymphatics
; alveolar ducts, alveoli, respiratory bronchioles lined with acidophilic, homogeneous or granular membrane
# *Ãâ»ýÈÄ 6-8hrÀ̳»¿¡ »ç¸ÁÇÑ
°æ¿ì¿¡´Â Ư¡ÀûÀÎ hyaline membraneÀÌ µå¹°´Ù.
Clinical Manifestations
; *usually
appear within minutes of birth
; Characteristically
- tachypnea, prominent(often
audible) grunting, intercostal & subcostal retractions, nasal flaring,
duskness
; increasing cyanosis
; breath sound
- normal or diminished with a harsh tubular quality
- fine rales on deep inspiration
; natural course
- progressive worsening of cyanosis & dyspnea
; *apnea
& irregular respiration
-
*tired infantÀ϶§
¹ß»ýÇÏ´Â ominous signs
- immediate intervention
; mild casesÀÎ °æ¿ì¿¡´Â symptoms & signs ÀÌ 3ÀÏÀ̳»¿¡ peak
; ¡ÚDeath
-
*rare on 1st day of illness
-
*usually 2-7 days
-
*ass. with alveolar air leaks(interstitial
emphysema, pneumothorax), pulmonary or intraventricular hemorrhage
Diagnosis
# ¡Ø87 X-ray
; not pathognomonic
;
*fine reticular granularity and
air bronchogram
- more prominent early in the Lt. lower lobe due to cardiac shadow
; occasionally normal initial roentgenogram
--> develop typical pattern at 6-12hr
; poor correlation between X-ray finding and clinical course
¡Ø89
Differential Diagnosis
; group B streptococcal sepsis
- gram-positive cocci in the gastric or tracheal aspirates & buffy coat smear
- positive test of urine for streptococcal antigen
; cyanotic heart disease
; PFC
; aspiration syndrome
; spontaneous pneumothorax, diaphragmatic eventration, congenital anomalies (cystic adenomatoid malformation, pulmonary lymphangiectasia, diaphragmatic hernia, lobar emphysema)
; transient tachypnea
; congenital alveolar proteinosis
Prevention
# Prevention Of Prematurity
;
*¡ãimportant
# *administration
of dexamethasone or betamethasone to women 48-72hr before delivery of fetuse at
32wk or less
; IVH, PDA, pneumothorax, NEC ÀÇ ºóµµµµ °¨¼Ò
# administration of 1 dose of surfactant
; »ýÈÄ 24½Ã°£ À̳»
Treatment
; most cases of HMD
-
*self-limiting
# goals
; minimize abnormal physiologic variations & superimposed iatrogenic problems
# general principles
; gentle handling, minimal disturbance consistent with management
; 36.5~37¡É core temperature
; IV calorie & fluid infusion
- 1st 24hrs
/ 10% DW 65-75 ml/kg/24hr
- subsequent
/ 120-150 ml/Kg/24hr with electrolyte
# warm humidified oxygen
;
¡ÚPaO2 À» 55-70
mmHg·Î À¯Áö
-->
¡Ø87
70% O2 conc. ¿¡¼µµ
50mmHgÀÌ»ó À¯Áö¾È µÇ¸é
-->
*CPAP 6-10 cm H2O by
nasal prongs
# ¡Ø86,92 Indications For Mechanical Ventilation
; arterial blood pH <7.20
; arterial blood PCO2 of 60 mmHg or more
; arterial blood PO2 of 50 mmHg or less at O2 70-100%
; presistent apnea
# ¢Þ96 Acceptable Range Assisted Ventilation
; PaO2 of 55-70mmHg
; PCO2 of 35-55mmHg
; pH of 7.25-7.45
; PEEP 4-6cmH2O
# rate ranges of ventilators
; conventional ventilator - 10~60 breaths/min
; HFJV - 150~600/min
; oscillators - 300~1800/min
# ¢¾Advantage
of HFJV & oscillators
; more CO2 elimination
; lower mean airway pressure
; occasionally improve oxygenation of patients not responding conventional ventilator
# ¢ÀComplication
of HFJV
; necrotizing tracheal damage, esp. in hypotension or poor humidification
; gas trapping
# ¢ÀComplication
of oscillator
;
*increased risk of air leaks, IVH,
PVL
; gas trapping
# ¡ÚSurfactant Therapy
;
*via E-tube, every 12hrs for a
total of 4 doses
; BPDÀÇ incidence¸¦ ³·ÃßÁö´Â ¾Ê´Â´Ù.
;
¡Ø94ÁÖ Immediate Effests
- improved aloveolar-arterial oxygen gradients
- reduced ventilator mean airway pressure
- imcreased pulmonary compliance
- improved appearance of X-ray finding
;
¢¾Á¾·ù
- Exosurf
/ synthetic
/ contain dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol
/ latter two protein for improving spread
- ALEC (artificial lung expanding compound)
/ 7:3 mixture of dipalmitoyl-phosphatidylcholine and phosphatidylglycerol
- survanta
/ from minced bovine lung with lipid extraction
/ enriched phosphatidylcholine, palmitic acid, TG
/ no SP-A
- Curosurf, infasurf
/ natural
;
¢¾Complications
-
*transient hypoxia and
hypotension, pulmonary hemorrhage, blockage of E-tube
# ¡Ø89 Alkali Therapy Complication
; skin sloughs due to
infiltration
; increased serum osmolarity
; hypernatremia
; hypoglycemia
; hypokalemia
; liver injury
# Umbilical artery catherization
;
*above bifurcation of the
aorta(L3-L5)
;
*above the celiac axis(T6-T10)
;
¡Ø87,93,94
Indication Of Removal
- stable PaO2 & less than 40% of FiO2
# AB medication ; routine
Complications Of HMD And Intensive Care
¡Ø82,84,90
Complication Of Tracheal Intubation
; asphyxia, cardiac arrest during intubation or suctioning, subglottic stenosis
-
*¡ãserious complication
; bleeding d/t trauma, post. pharyngeal pseudodiverticula, difficult extubation, ulceration of nares, permanent narrowing of the nostril, scarring from the irritation or infection, erosion of the palate, avulsion of the vocal cord, laryngeal ulcer, persistent hoarseness, papilloma of a vocal cord, stridor or edema of the larynx
¡Ø86,93
Complication Of Umbilical Arterial Catheterization
1) vascular embolization
2) thrombosis
/ heparin infusion 1-10unit/ml
3) spasm
4) preforation
5) ischemic or chemical necrosis of abdominal viscera
6) infection
7) accidental hemorrhage
8) impaired circulation to a leg with gangrene
9) renovascular hypertension
# ¡Ø85Áõ·Ê
Transient blanching of the leg
; due to reflex arterial spasm
; removal of catheter immediately
; Treatment
- topical nitroglycerin over femoral artery
- warming the opposite leg
- local infusion of tolazoline(Priscoline) 1-2mg intraarterial over 5min
Complication Of
Umbilical Vein Catheterization
; same as above
; portal hypertension & portal thrombosis
BPD
# Contributing factors
;
oxygen therapy - *¡ãimportant
; alveolar shear stress, volutrauma, hypocapnic saponification, absorption atelectasis, and subsequent inflammation
# Clinical course
; HMD·Î Ä¡·áÇÏ´ø ȯ¾Æ°¡ 3-4Àϰ È£Àüº¸ÀÌÁö ¾Ê°í, ´õ ¾ÇȵÊ
; X-ray changing
- from complete opacification with air bronchogram & interstitial emphysema
to
*small, round, lucent area
resembling sponge
; histologic finding(10-20days)
- less evidence of HM formation
- progressive alveolar coalescence with atelectasis
- interstitial edema
- coarse focal thickening of basement membrane
- mucosal metaplasia & hyperplasia
; surviving infant
-
*most recover at 6-12mo
- some prolonged hospitalization & respiratory symptom
; cause of death
-
*Rt sided heart failure, viral
necrotizing bronchiolitis
- pathology
/ cardiac enlargement
/ emphysematous alveoli with hypertrophy of peribronchial smooth muscle of tributary bronchioles
/ perimucosal fibrosis
/ widespread metaplasia of bronchiolar mucosa
/ thickening of BM
# ¡Ø94 Risk factor
; *prolonged periods of mechanical ventilation and oxygen therapy
-
*¡ãimportant
; *pulmonary interstitial emphysema, lower GA, male sex, low PCO2 at 48hr, *PDA, high PIP, increased airway resistance in the 1st wk of life, family Hx of asthma
# ¡ÚAcceptable
Blood Gas
; PCO2 of 50-70mmHg(if pH>7.30)
; PO2 of 55-60mmHg
; O2 saturation 90-95%
Treatment
; bronchodilators(aerozoliaed ¥â-adrenergic), theophylline, diuretics
; fluid restriction
; treatment of infection
; high caloric density formula
; CPAP for tracheomalacia
;
¡ÚDexamethasone
- 0.5mg/kg/24hr IV two dose after 2-6wk of chronic lung disease
- continued for 3 days
- reduced to 0.3mg/kg/24hr for additional 3 days
- reduced by 10% every 3 days until 0.1mg/kg/24hr
- final dose every other day for 1wk
- complications
/ hypertension, poor growth, GI bleeding, hyperglycemia, infection, possible cardiomyopathy
;
¡ÚComplication
- growth failure, transient psychomotor retardation, parental stress, *nephrolithiasis, osteopenia, subglottic stenosis
Prognosis
# ¢¾Poor
Prognostic Signs
; prolonged ventilation, IVH, pulmonary hypertension, cor pulmonale, oxygen dependency beyond 1yr of life, extrapulmonary extravasation,
Extrapulmonary Extravasation
PDA
# ¡Ø87 Predisposing factors
; hypoxia, acidosis, increased pulmonary pressure secondary to vasoconstriction, severe hypotension, immaturity, local release of PG
# *Ãʱ⿡´Â bidirectional or Rt to Lt shunting
-->
*HMD È£ÀüµÇ¸é¼ Lt to Rt shunting
# ¡Ø81,82 Manifestations Of PDA
1) persistent apnea for unexplained reasons in an infant recovering from HMD
2) active heaving precordium, bounding peripheral pulse
3) CO2 retention
4) increasing oxygen dependency
5) cardiomegaly and increased pulmonary vascular marking
6) hepatomegaly
# ¡Ø94 Treatment Of PDA
; ´ëºÎºÐÀº general supportive measures, diuretics, fluid restriction¿¡ Àß ¹ÝÀÀ
; IV indomethacin
- 0.2 mg/Kg at 12- to 24hr intervals for 3 doses
or 0.1 mg/Kg/24hr for 6days
-
¡ÚContaindications
/ thrombocytopenia, bleeding disorders, oliguria, NEC, elevated Cr(>1.8mg/dl)
Anemia
;sampling
; oxygen dependent patient´Â *Hct 40%À¯Áö
Prognosis
; surfactant
- RDS mortality 40%°¨¼Ò ( not morbidity )
87.4 Transient
Tachycardia Of The Newborn (Respiratory Distress Syndrome Type II)
Clinical Manifestation
; term or normal preterm
; early onset
; tachypnea
; sometimes retraction or expiratory grunting
; occasionally cyanosis
- relieved by minimal oxygen
; 3ÀÏ À̳»¿¡ ½Å¼ÓÈ÷ ÁÁ¾ÆÁü
Pathogenesis
;
¡Úslow absorption of fetal lung fluid
-->
decreased pulmonary compliance
& tidal volume, increased dead space
Diagnosis
;
¡ÚChest X-Ray
-
*prominent pulmonary vascular
markings, fluid lines in ther fissures, overaeration, flat diaphragm,
occasionally pleural fluid
;
*uncommon hypoxemia, hypercapnia,
acidosis
; DDx with RDS
- sudden recovery, absence of reticular or air-bronchogram
87.5 Aspiration Of Foreign Material
; during prolonged labors and difficult delivery
; T-E fistula, esophageal and duodenal obstruction, GE reflux, improper feeding practices, depressant medicines
87.6 Meconium Aspiration
# meconium stain - 5-15% of births
->
*5% develops mecoium aspiration
->
*30% requires mechanical ventilation
-> 5-10% expires
Clinical Manifestations
; *small
airway obstruction
--> respiratory distress within the 1st hr with tachypnea, retraction, grunting, cyanosis
; *pneumothorax,
pneumomediastinum
; overdistension of chest
; usually improve within 72hr
; ¡ØX-ray
- patchy infiltrates, coarse streaking of both lung fields, increased A-P diameter, flattening of diaphragm
Prevention
; fetal distress monitoring
; *aminoinfusion
& DeLee suctioning of oropharynx after head delivered
Treatment
; absence of fetal distress with thin meconium stained
- no treatment
; depressed infant and thick meconium stained
-
*intubation & suction
; standard RDS management
; surfactant therapy, inhaled nitric oxide, ECMO
- refractory conventional or HFJV therapy°æ¿ì¿¡ °í·Á
Prognosis
; asphyxiaÈÄÀÇ CNS injury¿Í µ¿¹ÝµÈ ´Ù¸¥ problem¿¡ ÀÇÇØ °áÁ¤
87.7 Primary Pulmonary Hypertension-PFC
; term and postterm
# ¡ÚPredisposing Factors
; birth asphyxia, meconium aspiration pneumonia, GBS sepsis, HMD, hypoglycemia, *polycythemia, pulmonary hypoplasia due to diaphragmatic hernia, amniotic fluid leak, *oligohydramnios, pleural effusion
# *idiopathic
Àϼöµµ ÀÖ´Ù.
Pathophysiology
; excessively high pulmonary vascular resistance
--> pulmonary hypertension
--> Rt to Lt shunting
; ¡ÚMechanism
1) maladaptive from an acute injury
2) increased pulmonary artery medial muscle thickness & extension of smooth muscle layers into nonmuscular more peripheral pulmonary arterioles in response to chronic fetal hypoxia
3) pulmonary hypoplasia
4) obstructive owing to polycythemia or total anomalous pulmonary venous return
5) alveolar capillary dysplasia
- lethal familial disorder
- thickened alveolar septum, reduced small pulmonary arteries & capillaries
Clinical Manifestations
; *ill
within first 12hr
; severe cyanosis with tachypnea
- polycythemia, idiopathic cause, hypoglycemia, asphyxia·Î ÀÎÇÑ °æ¿ì
; cyanosis, grunting, flaring, retractions, tachycardia, shock
- meconium aspiration, group B streptococcal pneumonia, diaphragmatic hernia, pulmonary hypoplasia·Î ÀÎÇÑ °æ¿ì
; *multiorgan
involvement
- myocardial ischemia, papillary muscle dysfunction with MR, TR, cardiac stun
Diagnosis
; *cyanosis°¡
ÀÖ´Â all term infant´Â
¹Ýµå½Ã ÀǽÉ
; *hypoxia
- universal
-
*unreponsive to 100% oxygen
- transient response to hyperoxic hyperventilation administered after endotracheal intubation or application of a bag & mask
; PaO2 gradient >20mmHg
- preductal(Rt. radial artery) & postductal(umbilical artery)
; *idiopathic
ÀÎ °æ¿ì¿¡´Â chest X-ray °¡ Á¤»óÀÌ´Ù.
; DDx
- cyanotic heart disease, associated etiologic entities that predispose to PFC
Treatment
# Initial management
; oxygen administration
; correction of acidosis, hypotension, and hypercabia
# Mechanical Ventilation Without Pancuronium Paralysis
;
*PaO2 of 50-70mmHg
& PaCO2 of 50-55mmHg
; tolazoline 1mg/kg
- nonselective ¥á-adrenergic antagonist
# Hyperventilation
;
*PaCO2 of 20-25mmHg
& increasing pH of 7.50-7.60
; use pancuronium
;
*conventional ventilation¿¡
È¿°ú ¾ø´Â
°æ¿ì
;
¡ÚComplication
- hyperinflation with reduced CO2 elimination
- reduced cardiac output
- barotrauma
- pneumothorax
- decreased cerebral blood flow
- increased fluid requirements
- edema resulting from pancuronium paralysis
; alkalination with sodium bicarbonate
- pul. arterial vasodilatation
# Exogenous surfactant therapy
# Inhaled NO ; 10-20ppm(usually 50)
# Alveolar-Arterial Oxygen Gradient
;
*[760-47] - PaCO2 - PaO2
;
*predictor of mortality(80%ÀÌ»ó)
# Oxygenation Index
;
*(mean airway pressure x FiO2 x
100) / postductal PaO2
;
*predictor of mortality(80%ÀÌ»ó)
# ECMO
;
¢¾Indication
- PFC
-
AaDO2 gradients greater than *620 for 8-12hr
-
*OI more than 40
- severely ill infants with HMD, meconium aspiration pneumonia, group B streptococcal sepsis
- hypoxic diaphragmatic hernia
/
*ventilation index(rate X mean
airway pressure) exceeds 1000 & PaCO2 exceeds 40mmHg
; veno-arterial bypass
- Rt. internal jugular vein & carotid arteryÀÌ¿ë
; Circuit
- *80% of estimated cardiac output(150-200ml/kg/min)À» µ¹¸°´Ù.
- rate of ECMO flow´Â venous oxygen saturationÀ» >65%À¸·Î À¯ÁöÇϵµ·Ï ÇÑ´Ù.
-
*ventilator support´Â room air·Î weaning at low rate
& pressure
;
¢¾Contraindication
- risk of IVH
/ <2kg, <35wk
- irreversible lung disease
- sign of systemic bleeding
- severe asphyxia
- lethal malformations
;
*7-10days·Î ventilationÇØ¾ßÇÑ´Ù.
;
¢¾Complication
-
thromboembolism, air embolization, bleeding, stroke, seizures, atelectasis,
cholestatic jaundice, thrombocytopenia, neutropenia, hemolysis, infectious
complications, edema formation, *systemic hypertension
Prognosis
# associated hypoxic-ischemic encephalopathy¿Í pulmonary vascular resistanceÀÇ °¨¼Ò¿¡ ´Þ·ÁÀÖ´Ù.
# *ECMOÈÄ outcomeÀÌ ÁÁ´Ù
;
*85-90% survival, 70-75% normal
1yr life
87.8 Extrapulmonary
Extravasation Of Air (Pneumothorax, Pneumomediattinum, And Pulmonary
Interstitial Emphysema)
;Asymptomatic pneumothorax - 1~2% of all newborn infants
; more common in females and in term and postterm
# ¡Ø87ÁÖ
Predisposing Factors
- meconium aspirtion
- HMD
- vigorous resuscitation
- assisted ventilation, esp. high inspirtory pressure
- urinary tract anomalies
Etiology And Pathophysiology
# overinflation resulting in alveolar rupture
; *¡ãcommon cause
; spotaneous(=idiopathic) or secondary
# secondary pneumothorax
; underlying pulmonary disease such as lobar emphysema or rupture of congenital or pneumonic cyst
; trauma
; ¡°ball-valve¡± type of bronchial or bronchiolar obstruction from aspiration
# Air leak ½Ã±â
1)
*within 24hr
;
*asso. with pulmonary hypoplasia
;
*others ass. with
- decreased amniotic fluid volume
/ Potter syndrome
: renal agenesis, renal dysplasia, chronic amniotic fluid leak
- decreased fetal breathing movement
/ oligohydramnios, neuromuscular disease
- pulmonary space-occupying lesion
/ diaphragmatic hernia, pleural effusion, chylothorax
- thoracic abnormalities
/ asphyxating thoracic dystrophies
2) 24-36hr
; meconium aspiration, pneumonia, HMD when lung compliance is reduced
3)
*after 36hr
;
*recovery phase of HMD if
inspiratory pressure & PEEP are not reduced
Interstitial Emphysema
; air from a ruptured alveolus escapes into interstitial spaces of the lung
Tension Pneumothorax
; elevate intrapleural pressure above atmospheric pressure
; compression of the vena cava and torsion of the great vessel
--> impaired venous return
Clinical Manifestation
# asymptomatic ; hyper-resonance and diminished breath sounds
# symptomatic
; tachypnea, dyspnea, and cyanosis
;
*irritability, restlessness or
apnea
-
*earliest sign
; chest
- asymmetric, increased A-P diameter, bulging of the intercostal spaces
; shock
Pneumomediastinum
; *25%
of pneumothorax patients
; *usually
asymptomatic
, midthoracic bulging, neck vein distension, BP decreasing
; *subcutaneous
emphysema
-
*pathognomonic
Pulmonary Interstitial Emphysema
; precedes the development of a pneumothorax or independently develop
; in severe cases
- precedes development of BPD
Diagnosis
# pneumothorax
; collapsed lungÀÇ edge°¡ ¶Ñ·ÇÀÌ »çÁø»ó º¸ÀÓ
# pneumomediastinum
; heart ÁÖÀ§¿Í heart, sternum»çÀÌ¿¡ hyperlucency°¡ º¸ÀÓ
# transillumination of the chest
# *associated
renal anomaly À» °Ë»çÇØ¾ß
ÇÑ´Ù.
; USG
# ¢¾Pulmonary
HypoplasiaÀ» ÀǽÉÇÒ
¼ö ÀÖ´Â
°æ¿ì
; uterine compression(extremity contractures)
; small thorax on chest roentgenogram
; severe hypoxia with hypercarbia
; sign of primary disease(hypotonia, diaphragmatic hernia, Potter syndrome)
Pneumopericardium
; sudden shock with tachycardia, muffled heart sound, and poor pulses
Pneumoperiteneum
Treatment
; asymptomatic or mildly symptomatic
- only observation
; *breathing
100% oxygen
- accelerates the resorption of free pleural air into blood
; selective bronchial intubation
; use of pavulon
87.9 Interstitial Pulmonary Fibrosis
# Wilson and Milkity syndrome
; <1500 g, <32wks, *without history of RDS, incidious onset of dyspnea, tachypnea, retraction and cyanosis during the 1st 1mo
# symptoms and signs
cough, wheezing, and rales
Rt. sided heart failure
# diagnosis
; X-ray
- bilateral coarsereticular streaky infiltration
- overexpansion with small area of emphysema
# DDx
; pneumonia d/t CMV, pneumocystis carinii, Ureaplasma urealyticum, or chlamydia pneumonia
; cystic fibrosis
# treatment
; supportive care; oxygen, bronchodilator, diuretics, acid-base correction, correction of anemia, assisted ventilation
; a trial of EM
87.10 Pulmonary
Hemorrhage
# Incidence
; 15% of neonates in the 1st 2wks(at autopsy)
; 1-4/1,000 live birth
; 3/4 of patients - less than 2,500 g
Clinical Manifestation
; respiratory distress
; *at
birth or delayed several days
; variable chest X-ray finding
Etiology
; not identified
# ¡Ø82 Asso. disorders
;
acute pulmonary infection, severe asphyxia, HMD, surfactant therapy, assisted
ventilation, CHD, erythroblastosis fetalis, *hemorrhagic
ds. of newborn, kernicterus, inborn error of ammonia metabolism, cold injury
; DIC
; Lt. heart failure
- hemorrhagic pulmonary edema
Prognosis
; poor
- death in 1st 48hr of life
- 2/3
Chapter 88. Digestive System Disorders
Vomiting
; *´ëºÎºÐÀº simply regurgitation from overfeeding or from failure to
permit infant to eructate swallowed airÀÌ ¿øÀÎÀÌ´Ù.
# Bile-stained emesis
;
*intestinal obstruction beyond
duodenum
; also be idiopathic
# Vomiting In Esophageal Atresia
; occurs with first feeding
; suspected if unusual drooling from the mouth
; infant chokes on oral feedingÀÌ µÇ±âÀü¿¡ Áø´ÜµÇ¾î¾ß ÇÑ´Ù.
# Vomiting due to obstruction of small intestine
; begins on the 1st day
; frequent, persistent, usually nonprojectile, copious
; bile-stained
; abdominal distension, visible deep peristaltic waves
; reduced or absent bowel movement
;
*Normal Gas Pattern
- in the jejunum by 15-60 min
- in the ileus by 2-3hr
- in the colon by 3hr after birth
# persistent vomiting ; diaphragmatic hernia
# begins in the 2nd-3rd wks of life ; pyloric stenosis
# celiac disease, milk allergy, adrenal hyperplasia, galactosemia, hyperammonemia, IICP, septicemia, menigitis, UTI
Thrush(Oral Candidosis)
; healthy infant
- transmission from maternal vaginal moniliasis
- transmission from hospital nursery
; debilitated infants
- more common
- receiving antibiotic or immunosuppressive therapy
- AIDS
Diarrhea
Constipation
¡Ø97 No Meconium Pass Within 36hr After Birth
; intestinal obstruction
; congenital aganglionic megacolon
; milk bolus obstruction
; meconium ileus
; meconium plug
# *Present
During The 1st Mo Of Life
; CMC, cretinism, anal stenosis
Meconium Plugs
; *associated
with small lt. colon syndrome in the infants of a diabetic mother, cystic
fibrosis, rectal aganglionosis, maternal drug abuse, MgSO4 therapy for
pre-eclampsia
; ¡Ø87ÁÖ
Treatment
- evacuated by irrigating with isotonic sodium chloride solution
- enemas with iodinated contrast medium gastrograffin
; *Á¦°ÅÈÄ¿¡µµ
¼¼½ÉÇÑ °üÂûÀÌ
¿äÇÑ´Ù.
-
*possible presence of congenital
aganglionic megacolon
88.1 Meconium Ileus In Cystic Fibrosis
1. symptoms and signs
1) abdominal distension
2) persistent vomiting
2. diagnosis
1) presumptive ; Hx of cystic fibrosis in a sibling
2) palpation of doughy or cord like massof intestine
3) X-ray finding
3. treatment; gastrograffin enema
Meconium Peritonitis
abdominal distension, vomiting, and absence of stool
88.2 Neonatal
Necrotizing Enterocolitis
; incidence - 1-5% of admissions of NICU
; rarely in term infants
Pathology And Pathogenesis
; pneumatosis intestinalis
; *distal
ileum and proximal colon
-
*¡ãcommon
# ¡ÚRisk
Factors
; polycythemia, hypertonic milk or medicine, too rapid feeding protocol
; *pemature¿¡¼´Â stress ¾øÀÌ ÀϾ
¼ö ÀÖ´Ù.
; *infectious
agents °¡ Áß¿äÇÑ
¿ªÇÒ
-
*Cl. perfringens, E. coli, Sta.
epidermidis, rotavirus
Clinical Manifestation
; *onset
in first 2wks
- as late as 2mo in VLBW infants
; *abdominal
distension with gastric retension
-
*first sign
; bloody stool
- 25% of patients¿¡¼ °üÂûµÇ°í, insidous onsetÀ» º¸À̱⵵ ÇÔ.
Diagnosis
# ¡Ø92,93 X-Ray Findings
; pneumatosis intestinalis
- diagnostic finding
-
*50-75%¿¡¼¸¸
°üÂûµÈ´Ù.
; portal vein gas
-
*sign of severe disease
; pneumoperitonium
- perforationÀǹÌ
# Differential Diagnosis
;
obstruction, volvulus, indomethacin¿¡
ÀÇÇØ perforation¹ß»ý½Ã´Â NEC¿Í´Â ´Þ¸® *less ill-apearanceÀ» º¸ÀδÙ.
Treatment
; cessation of feeding, nasogastric decompression
; fluid therapy
; systemic antibiotics
- antipseudomonas(e.g. ticarcillin) and aminoglycoside
; ventilation
; ¡ØSurgery
- evidences of perforation
- failure to respond to medical management
- single fixed bowel loop
- erythema of the abdominal wall or a mass
Prognosis
; medical management failure with pneumatosis intestinalis
-
*20%
- ÀÌÁß 25%´Â die
# Complications
; short bowel syndrome due to massive resection
# Prevention
; jucidious feeding protocols
88.3 Jaundice And Hyperbilirubinemia In The Newborn
# Indirect bilirubin
; unconjugated, nonpolar, lipid-soluble pigment
; formed from hemoglobin
; by heme oxygenase, biliverdin reductase, nonenzymatic reducing agents in RES system
; neurotoxin
# Direct bilirubin
; polar, water-soluble ester glucuronide of bilirubin
; converted in liver cell microsome
; by uridine diphosphoglucuronic acid(UDPGA) glucuronyl transferase
Etiology
# ¢ÀUnconjugated
Hyperbilirubinemia
1) increase the load of bilirubin
; hemolytic anemia, shortened red cell life due to immaturity or to transfuesd cells, increased enterohepatic circulation
2) damage or reduce the activity of the transferase enzyme
;
hypoxia, infection, possibly hypothermia, *thyroid
deficiency
3) compete for or block the transferase enzyme
; drugs & other substances requiring glucuronic acid conjugation for excretion
4) leads to an absence of or decreased amounts of the enzyme or to reduction of bilirubin uptake bt the liver cell
;
genetic defect, *prematurity
# ¡Ø90 Increasing Factors
; hypoproteinemia
; sulfisoxazole & moxalactam
- displacement of bilirubin from its binding sites on albumin by competitive binding
; acidosis
;
*increased FFA conc. due to
hypoglycemia
; starvation
; hypothermia
# ¡Ø91 Factors that increse permeability of BBB or nerve cell
memb to bilirubin or susceptibility of brain cells to its toxicity
; asphyxia
; prematurity
; hyperosmolality
; infection
Clinical Manifestation
; begins on face
- face-5mg/dl, midabdomen-15mg/dl, soles-20mg/dl
; indirect bilirubin - bright yellow or orange
direct bilirubin - greenish or muddy yellow
¡Ø¡ÚDifferential Diagnosis
# 1st 24hrs
; erythroblastosis fetalis, cytomegalic inclusion disease, concealed hemorrhage, sepsis, rubella, congenital toxoplasmosis
# 2nd Or 3rd Day
; physiologic,
*Crigler-Najjar Syndrome
# After The 3rd Day And Within The 1st Wk
; septicemia, infection(syphilis, toxoplasmosis, cytomegalic inclusion disease)
; polycythemiaµµ early jaundice À¯¹ß
# ¡ÚAfter
The 1st Wk Of Life
; breast milk jaundice, septicemia, *congenital atresia of bile duct, hepatitis, rubella, herpetic hepatitis, galactosemia, hypothyroidism, congenital hemolytic anemia, crisis of other hemolytic anemia, hemolytic anemia due to drugs
# ¡Ø90ÁÖ
Persistent Jaundice During 1st Mo
; inspissated Bile Syndrome, hyperalimentation-associated cholestasis, hepatitis, cytomegalic inclusion disease, syphilis, toxoplasmosis, familial nonhemolytic icterus, congenital atresia of bile duct, galactosemia, hypothyroidiam, pyloric stenosis
# Direct Bilirubinemia
; hepatitis, cholestasis, inborn error of metabolism, cystic fibrosis, sepsis
Physiologic Jaundice (Icterus Neonatorum)
; visible 2nd-3rd day
- rising rate <5 mg/dl/24hr
- peaking between the 2nd and 4th day at 5-6 mg/dl
- decreasing to <2 mg/dl btw 5th and 7th day
# ¡ÚPathogenesis
; increased bilirubin production following breakdown of fetal red blood cells
; transient limitation in the conjugation of bilirubin by the liver
; 6-7% of full-term - greater than 12.9mg/dl
; 3% of full-term - greater than 15mg/dl
#
Risk Factors For Indirect Hyperbilirubinemia
; maternal diabetes, race(Chinese, Japanese, Korean, and Native American), prematurity, drugs(vitamin K3, novobiocin), altitude, polycythemia, male sex, 21-trisomy, cutaneous bruising, cephalhematoma, oxytocin induction, breast feeding, weight loss, delayed stooling, sibling who had physiologic jaundice
# ¡ÚPersistent
Indirect Hyperbilirubinemia Beyond 2wk
; hemolysis, hereditory glucuronyl transferase deficiency, breast milk jaundice, hypothyroidism, intestinal obstruction
# ¢¾Cause
of Hyperbilirubinemia in Pyloric Stenosis
; caloric deprivation
; deficiency of hepatic UDP-glucuronyl transferase
; ileus-induced increased enterohepatic circulation of bilirubin
# ¢ÞNeed For Search (Not Physiologic Jaundice)
1) appears in the 1st 24hrs of life
2) serum bilirubin is greater than 12 mg/dl in full-term or 10-14 mg/dl/24hr in preterm infant
3) serum bilirubin is rising at a rate greater than 5 mg/dl/24hr
4) jaundice persists after the 2nd wk of life
5) direct-reacting bilirubin is greater than 1mg/dl at any time
Pathologic Hyperbilirubinemia
; risk factor
- Asian race, prematurity, breast-feeding, or weight loss
; ¡Ø90 low bilirubin level¿¡¼µµ kernicterus°¡
¹ß»ýÇÏ´Â °æ¿ì
- preterm infants
- asphyxia
- IVH
-
*hemolysis
- drug
Jaundice Associated With Breast-Feeding
# max. concentration
;
*10-30 mg/dl during the 2nd-3rd wk
# breast feeding Áö¼Ó½Ã, *3-10wk±îÁö low level·Î Áö¼ÓµÉ
¼ö ÀÖ´Ù.
# cessation of BMF
; 1-2Àϳ»¿¡ ¶³¾îÁö°í, feedingÀ» ´Ù½Ã ÇØµµ ¿Ã¶ó°¡Áö ¾Ê´Â´Ù.
# ¢¾¿øÀÎ
1) increase enterohepatic circulation
; increased caloric intake, delayed passage of meconium, increased level of beta glucuronidase, decreased urobilin formation
2) inhibit glucuronyl transferase
; increased concentration of pregnanediol in milk
-
5-¥â-pregnane-3¥á,
20-¥â-diol
;
*increased concentration of
nonesterified fatty acid in milk - more important
# ¢¾DDx
from early onset accentuated unconjugated hyperbilirubinemia
; higher bilirubin levels in 1st wk
; due to decreased milk intake with dehydration or reduced caloric intake
; Tx
- frequent breast feeding(>10/24hr), rooming-in with night feedings
- discouraging 5% dextrose or water supplementation
Transient Familial Neonatal Hyperbilirubinemia
; glucuronyltransferase inhibiting factor
Neonatal Hepatitis
Congenital Atresia Of The Bile Ducts
; jaundice persisting for more than 2wk or associated with acholic stools and dark urine
Inspissated Bile Syndrome
88.4 Kernicterus
; unconjugated biliubinÀÌ brain cell¿¡ Ä§ÂøµÇ¾î »ý±â´Â neurologic syndromeÀÌ´Ù.
; *erythroblastosis
fetalis°¡ ÀÖ´Â infant´Â serum bilirubin level°ú kernicterus°¡ Á÷Á¢ÀûÀÎ
¿¬°ü¼ºÀÌ ÀÖÀ¸³ª healthy term infant¿¡¼´Â ±×
¿¬°ü¼ºÀÌ ºÒºÐ¸íÇÏ´Ù.
; exceeding bilirubin binding capacity of albumin & other plasma protein and increasing plasma free bilirubin levels
- enter brain by diffusion
; healthy term infant without hemolysis
-
*serum levelÀÌ 25mg/dlÀÌ»óÀÌ µÇ¾î¾ß kernicterus°¡ ³ªÅ¸³´Ù.
; *the
less mature the infant, the greater the susceptibility to kernicterus
- VLBW infant´Â 8-12mg/dlÀÇ Á¤µµ¿¡¼µµ kernicterus°¡ ³ªÅ¸³´Ù.
Clinical Manifestation
; term infant - 2-5days after birth
premature - 7th day
; initial sign
- lethargy, poor feeding, loss of the Moro reflex
; *gravely
ill, diminished tendon reflex, resp. distress
; opistotonus with bulging fontanel, twitching of face or limb, shril high-pitched cry
; convulsion, spasm
; rigidity is rare
; severe neurologic signÀ¸·Î ÁøÇàÇÑ È¯¾ÆÀÇ ´ëºÎºÐ »ç¸Á
- survivors few symptom for 2-3mo
/ 1³âÈÄ ; opisthotonus, muscular rigidity, irregular movement and convulsion
/
2³âÈÄ ;
opisthotonus, seizure´Â °¨¼ÒÇϳª, *irregular,
involuntary movement, muscular rigidity, hypotonia´Â
°è¼ÓÁõ°¡ÇÑ´Ù.
/ 3³âÈÄ
: complete nuerologic synd ÀÌ ºÐ¸íÇØÁø´Ù.
: bilateral choreoathetosis with involuntary muscle spasm, extrapyramidal sign, seizure, mental deficiency, dysarthric speech, high frequency hearing loss, squint(»ç½Ã), defective upward movement of the eye
: pyramidal sign, hypotonia, ataxiaÀº ¼Ò¼ö¿¡¼ ³ªÅ¸³´Ù.
; in midly affected infants
- mild to moderate neuromuscular incoordination, partial deafness, minimal brain dysfunction
Pathology
; the surface of the brain is usually pale yellow
; stained yellow by unconjugated bilirubin
-
particularly in *corpus subthalamicum,
hippocampus & adjacent olfactory area, striate body, thalamus, globus
pallidus, putamen, inferior clivus, cerebellar nuclei, cranial nerve nuclei
; non pigmented areas may also be damaged
- loss of neuron, reactive gliosis, atropy of involved fiber system
; injury hypothesis
-
*bilirubin interferes with oxygen
utilization by cerebral tissue
Incidence & Prognosis
; untreated hemolytic ds. with more than 20mg/dl bilirubin level
- 1/3 kernicterus
# Poor Prognosis
; overt neurologic sign
-
*75% ÀÌ»ó die
- 80% of affected survivor
/ bilateral choreoasthetosis with involuntary muscle spasm
/ mental retardation, deafness, spastic quadriplegia
Treatment Of Hyperbilirubinemia
# goal of therapy
; to prevent the concentration of indirect reacting bilirubin in the blood from reaching levels at which neurotoxicity may occur
# underlying cause Ä¡·á
; neurologic damageÀÇ À§Ç輺À» Áõ°¡½ÃŰ´Â physiologic factorÀÇ Ä¡·á (eg. correction of acidosis)
# *6-12hrÀ» phototherapy¸¦ ÇØ¾ß
È¿°ú¸¦ ¾Ë
¼ö ÀÖ´Ù
Exchange Transfusion
¢ÞTable
88-2, 88-3
; ÀÌ ±âÁØÀº ¿©·¯ °¡Áö factor¿¡ÀÇÇØ º¯°æµÉ ¼ö ÀÖ´Ù.
; *clinical
signÀÌ ³ªÅ¸³ª¸é serum bilirubin level¿¡ »ó°ü¾øÀÌ exchange transfusionÀÇ
indicationÀÌ µÈ´Ù.
; healthy fullterm infant(physiologic or breast milk jaundice)
- 25mg/dlÀ̻󿡼µµ Àß °ßµô ¼ö ÀÖ´Ù.
; sick premature infant - ³·Àº level¿¡¼µµ kernicterus°¡ ¹ß»ýÇÒ ¼ö ÀÖ´Ù.
Phototherapy
; bilirubin absorbs light maximally in the blue range(420-470nm)
# ¢¾Mechanisms
; by photoisomerization
-
*4z, 15Z-bilirubin ¡æ 4z, 15E-bilirubin
- excreted in bile without conjugation
; by irreversible reaction
-
*native bilirubin ¡æ isomer lumbirubin
- excreted by kidney in unconjugated form
; prophylactic phototherapy in VLBW infants may prevent hyperbilirubinemia and reduce the incidence of exchange transfusion
# ¡ÚMaximum
intensive phototherapy
; special blue fluorescent tubes
; within 15-20cm
; fiberoptic phototherapy blanket in infant¡¯s back
# ¡Ø°´ Serum Bilirubin Level°ú HematocritÀÇ Monitor
;
* every 4-8hr in infant with
hemolytic ds.
;
* older infant¿¡¼´Â 12-24hr interval
;
*phototherapy Áß´Ü ÈÄ¿¡µµ
Àû¾îµµ 24hrµ¿¾È moniter ÇØ¾ßÇÑ´Ù.
- since unexpected risese of bilirubin
# hemolytic disease°¡ Àִ ȯ¾Æ´Â anemia ¸¦ °£°úÇØ¼´Â ¾ÈµÈ´Ù.
- ÇÊ¿äÇϸé transfusion
# ¡Ø82 Complication of phototherapy
; loose stool, erythematous macular rash, overheating & dehydration, chilling from exposure of the infant, bronze baby synd.
# Contraindication
; porphyria
# ¡ÚBronze
Baby Synd.
; dark, grayish brown discoloration of the skin undergoing phototherapy
; mixed type of hyperbilirubinemia with elevation of direct bilirubin
; last for many months
Phenobarbital
; physiologic jaundice¿¡ ÇÑÁ¤µÈ »ç¿ë
; enhance the conjugation and excretion of bilirubin
# not routinely recommanded for treating jaundice in the neonatal infant
;
¡Ø96°´ ÀÌÀ¯
- Åõ¿©ÇÏ°í ¸çÄ¥ÀÌ Áö³ª¾ß bilirubin metabolism¿¡ ¿µÇâÀ» ÁØ´Ù
- phototherapy º¸´Ù È¿°ú°¡ Àû´Ù
- untoward side effect°¡ ÀÖ´Ù
- not add to the response to phototherapy
Tin(sn)-protoporphyrin
; reduction of bilirubin level
Chapter 89. Blood Disorder
89.1 Anemia in the Newborn Infant
# fetal Hb increases with advancing gestational age
# at term, cord blood Hb ; 16.8g/dl (14-20g/dl)
- VLBW infant ; 1-2g/dl below those at term
# physiologic decrease
; 8-12wk in term infants(Hb 11g/dl)
; 6wk in premature(Hb 7-10 g/dl)
# Anemia at birth
; pallor, CHF or shock
; caused by hemolytic ds. of the newborn, tearing or cutting of the umbilical cord during delivery, abnormal cord insertion, commucating placental vessel, placenta previa or abruptio, nuchal cord, incision into the placenta, internal hemorrhage, thalassemia, congenital parvovirus infection or hypoplastic anemia, twin-twin transfusion in monozygotic twin with arteriovenous, placental connection
# Transplacental hemorrhage
; bleeding from the fetal into the maternal circulation
; *Kleihauer-Betke test
- maternal blood¿¡¼ fetal Hb°ú RBC¸¦ Áõ¸íÇÑ´Ù
Fig 89-2
#Acute blood loss
; result in severe distress at birth, initially with a normal Hb level, no hepatosplenomegaly, early onset of shock
# Chronic blood loss
; *marked pallor, less distress, low Hb level with microcytic
index
; if severe, CHF
# ¡Ø82,83,87ÁÖ
Anemia Appearing In The First Few Days After Birth
; hemolytic ds. of the newborn, hemorrhagic ds, bleeding from an improperly tied or clamped umbilical cord, large cephalhematoma, intracranial hemorrhage, subcapsular bleeding from rupture of the liver, spleen, adrenals or kidney
# *Delayed
anemia from hemolytic ds. of the newborn
; vitamin K in large dose in premature
- Heinz body in the erythrocyte
; congenital hemolytic anemia
- spherocytosis
- G-6-PD and pyruvate kinase deficiency
; bleeding from hemangioma of the upper GI tract or from ulcer (in a Meckel diverticulum or duplication)
; repeated blood sampling of infant
;
*deficiency of minerals such as
copper in TPN infant
# Anemia of prematurity
; 1-3mo, below 7-10g/dl
; apnea, poor weight gain, pallor, decreased activity, tachypnea, tachycardia, feeding problem
;
¡Ø±âÀü
- repeated phlebotomy for blood test
- shortened red blood cell survival
- rapid growth
- physiologic effects of the transition from fetal to neonatal life
- smaller iron store
- decreased erythropoietin
# Treatment of neonatal anemia by blood transfusion
; severity of symptoms, the Hb level, presence of co-mobid ds(BPD, HMD) ¿¡µû¶ó °áÁ¤
; asymptomatic full-term infant(10g/dl) may be observed.
; theophyllinÄ¡·á¿¡µµ ºÒ±¸Çϰí apnea, bradycardia°¡ ³ªÅ¸³ª´Â Hb 10g/dlÀÌÇÏÀÎ premature infant´Â RBC transfusionÀÌ µµ¿òÀÌ µÈ´Ù
;
*HMD, severe BPD´Â Hb 12-14g/dl À¯Áö
; PRC transfusion
- 10-15ml/kg, rate 2-3ml/kg/hr
- 2ml/kg ÁÖ¸é Hb 0.5-1g/dl ¿À¸¥´Ù
; Hemorrhage°¡ ÀÖÀ» ¶§
- whole blood ¶Ç´Â fluid therapyÈÄ PRC»ç¿ë
; Recombinant Human Erythropoietin(Rhuepo)
- chronic anemia ass. with prematurity & BPD
- anemia of prematurity ass. with low endogenous levels of serum erythropoietin, HuEpo-responsive erythrocyte progenitor cells
- oral iron, vit E °°ÀÌ °ø±Þ
- dose
/ 100-200U/kg/dose, 5day/wk
/ 400U/kg/dose, 3day/wk
/ 150-200U/kg/dose q 3day
89.2 Hemolytic Ds. Of The Newborn (Erythroblastosis Fetalis)
; passage of maternal Ab ¡æ increased rate of red cell destruction
; important cause of anemia and jaundice
; *¿øÀÎ(¼ø¼)
- D antigen of the Rh group, incompatibility of ABO factors
- C or E antigen
- K(kell), Duffy, Lutheran antigen
- Cw, Cx, Du, M, S, P, MNS, Xg, Diego, Kidd
; *Anti-Lewis
antibodies do not cause disese
Hemolytic ds. of the newborn due to Rh incompatibility
; 90% are due to D Ag
- others C or E
Pathogenesis
; unsensitized Rh negative recipient mother¿¡ Rh positve containing D AgÀÌ °¨ÀÛ
- by infused through error, inherited from Rh positve father during pregnancy, spontaneous or induced abortion
--> Ab formation
/
*19S (IgG) Ab°¡
óÀ½¿¡ Áõ°¡
/
*³ªÁß¿¡ 7S(IgG) Ab·Î ´ëÄ¡µÊ
- À̰ÍÀÌ cross the placenta & cause hemolytic manifestation
; ¢ÞWhy Hemolytic Ds Rarely Occurs During A First Pregnancy in
Rh incompitibility ?
- Rh(+) fetal blood transfusionÀÌ ´ëºÎºÐ delivery ½Ã±â¿¡ ÀϾ °¨ÀÛÀÌ µÇ°Å³ª Ab transmitÀ» ÇÒ ¼ö°¡ ¾ø´Ù.
- 55% of Rh positive fathers are heterozygous(D/d)
- Rh negative offspring
- 50% of fetal to maternal transfusions
- variable Ab formation of Rh(-) mother
; ¢ÞWhy Hemolytic Ds Rarely Occurs During A First Pregnancy in
ABO incompitibility ?
- rapid removal by anti-A or anti-B in moter circulation
- this IgM not cross placenta
; only about *5%
ever have babies with hemolytic ds
; prevention
- anti-D gamma globulin(RhoGAM), immediately following the delivery
Clinical Manifestation
; mild hemolysis to severe anemia
; massive enlargement of the liver and spleen due to compensatory hyperplasia of erythropoietic tissue
; Hydrops fetalis
- paller, sign of cardiac compensation(cardiomegaly, respiratory distress), massive anasarca, circulatory collapse
- severity´Â level of anemia, degree of reduction in serum albumin¿Í ¿¬°üµÇ¾î ÀÖ´Ù.
¡ÚTable
89-1
; petechia, purpura, thrombocytopenia
; DIC
; *jaundice´Â
ÀϹÝÀûÀ¸·Î ž
¶§´Â ¾ø°í
»ýÈÄ Ã¹³¯
ºÐ¸íÇØÁø´Ù
- Ãâ»ý¶§ ³ªÅ¸³ªÁö ¾Ê´Â ÀÌÀ¯´Â *placental clearance¶§¹®ÀÌ´Ù. ±×·¯³ª ½ÉÇÑ °æ¿ì´Â bilirubin pigmentationÀÌ amniotic fluid, cord, vernix¿¡ ³ªÅ¸³ª°í, yellow vernix caseosa°¡ µÈ´Ù.
; ¡Øhypoglycemia due to hyperinsulinism, hypertrophy of the
pancreatic islet cell
Laboratory Data
; direct Coombs test - positive
; anemia - hydrops fetalis(3-4g/dl)
; blood smear - polychromasia, nucleated RBCÁõ°¡
; reticulocyte Áõ°¡
; thrombocytopenia in severe case
; the cord bilirubin ; 3-5mg/dl
; After intrauterine transfusion
- normal Hgb conc.
- negative direct coomb¡¯s test
- predominantly type O Rh(-) adult red cells
- relatively normal smear
-
*marked elevation of both indirect
& direct reatcing bilirubin
Diagnosis
; definite diagnosis - blood group incomptibility and corresponding antibody
Antenatal Dx
; assay of maternal titer of IgG Ab to D
-
*12-16wk, 28-32wk, 36wk
;
¢¾Suggestive Significant Hemolytic Ds
- presence of measurable Ab titer at the beginning of pregnancy
- rapid rise in titer
- titer of 1:64 or greater
; ¡ÚMonitoring Of Severity Of Fetal Disease
- if Ab titer 1:16 or greater during subsequent pregnancy
- if previously affected infant or a stillbirth
-
¡Ø97 Fetal
hydrops monitoring methods
1) amniocentesis
2) percutaneous umbilical blood sampling(PUBS)
3) ultrasonography
# Real time ultrasound
; hydrops (skin or scalp edema, pleural or pericardial effusion, ascites)
;
¡ÚEarly ultrasonographic signs of hydrops
- organomegaly (liver, spleen, heart), double bowel wall sign (bowel edema), placental thickening
-
*pleural effusionÀÌ ascitesº¸´Ù ¸ÕÀú
¿À¸é ´Ù¸¥
¿øÀÎÀ» »ý°¢ÇØ
º¸¾Æ¾ßÇÑ´Ù
; Extramedullay hematopoiesis
¡æ hepatic congestion ¡æ compress the intrahepatic vessels
¡æ venous stasis with portal hypertension
¡æ hepatocellular dysfunction, decreased albumin synthesis
; hydrops°¡ ¿À´Â ºóµµ
- fetal Hb <5 g/dl - invariables
- < 7 g/dl - frequent
- 7-9 g/dl - variable
# ¢¾Amniocentesis
; bilirubin is cleared by the placenta, significant proportion enters the amniotic fluid
;
early as *18-20wks
; ¡ÚIndication
- Ab titer > 1:16
- father Rh(+)
- ultrasonography»ó hemolysis, hydrops, distress¼Ò°ß
; Spectrophotometric scanning
- positive OD deviation at 450nm at normal
- zone of OD 450ÀÌ zone IIIÀ̸é highest risk
-
*¹Ýµå½Ã life-threatening anemia³ª
intrauterine transfusionÀ» ÀǹÌÇÏÁö´Â
¾Ê´Â´Ù.
# ¢¾PUBS
Indication
; OD 450 in zone III
; hydrops
; other signs suggesting fetal anemia
Postnatal Diagnosis
; ABO blood group, Rh type, Hb, Hct, direct coombs
Treatment
# the main goal of therapy
; to prevent intrauterine or extrauterine death from severe anemia and hypoxia
; to avoid neurotoxicity from hyperbilirubinemia
Treatment Of Unborn Infant
; umbilical vein transfusion Ix
-
hydrops or fetal anemia *(Hct < 30%)
- post transfusion Hct ; 45-55%, repeated every 3-5wk
;
¢¾Indication For Delivery
- pulmonary maturity, fetal distress, complication of PUBS, 35-37wk of gestation
Treatment Of The Live Born Infant
; fresh, low titer, group O, Rh negative blood, cross-matched against the maternal serum
; correction of acidosis, small transfusion of compatible packed red blood cells
; volume expansion for hypotension
Exchange Transfusion
# ¢ÞIndication Of Early Exchange Transfusion
; cord Hb<10g/dl or bilirubin>5mg/dl
; previous kernicterus or severe erythroblastosis in sibiling
; reticulocyte count >15%
; prematurity
# dangerously high levels of serum bilirubin
; 6mg/dl in the first 6hr
; 10mg/dl in the second 6hr
; rates of rise > 0.5 - 1.0 mg/dl/hr
-->
but *unreliable marker
# Monitoring
; Hb, Hct, serum bilirubinÀº óÀ½¿¡ 4-6hr°£°ÝÀ¸·Î monitoring
¡¤blood type O, Rh negative donor with a low titer of anti-A and anti-B and
should be compatible with the mother's serum by indirect coombs test
¡¤transfusionÀü¿¡ infant stomachÀ» ºñ¿ö¾ßÇÑ´Ù(aspiration ¹æÁö)
body temperature À¯Áö
vital sign monitor
¡¤45-60ºÐ µ¿¾È 20ml¾¿ aspiration & infusion
;
*2 blood volume of the infant(2¡¿85ml/kg)
¡¤citrated blood ¡æ later metabolic alkalosis
;
¡Ø93ÁÖ Acute Complication (5-10% Infant)
- transient bradycardia with or without calcium infusion, cyanosis, transient vasospasm, thrombosis, apnea with bradycardia requiring resuscitation, infectious risk(CMV, HIV, hepatitis), NEC
; exchangeÈÄ¿¡ bilirubin 4-8½Ã°£¸¶´Ù check(d/t ¸î½Ã°£³»¿¡ 40-50% reboundÇÑ´Ù)
¡Ø93ÁÖ
Late Complication
; late anemia due to hemolytic or hyporegenerative
- Tx - supplemental iron, erythropoietin, blood transfusion
; mild graft versus host reaction
- diarrhea, rash, hepatitis, eosinophilia
; inspissated bile syndrome
- hemolytic ds.°¡ ÀÖ´Â infant¿¡¼ direct, indirect bilirubinÀÌ Áö¼ÓÀûÀ¸·Î Áõ°¡ÇØ ÀÖ´Â »óÅÂ
- jaundice´Â ¸î ÁÖ¿¡¼ ¸î ´Þ³»¿¡ ÀúÀý·Î »ç¶óÁø´Ù
; portal vein thrombosis
¡Ø96°´
Prevention Of Rh Sensitization
; human anti-D globulin 300ug im within 72hr of delivery or abortion
- 10mlÀÇ antigenic fetal cellÀ» Á¦°ÅÇÒ ¼ö ÀÖ´Ù
- 29-32ÁÖ and again at birth (40ÁÖ)
/ ´õÈ¿°úÀûÀÌ´Ù
/ large fetal-to-maternal transfer¿¡ »ç¿ë
Hemolytic disease of the newborn due to A & B incompatibility
; mother - type O, infant - type A or B
; ABO incompatibility´Â 20-25%¿¡¼ ¹ß»ýÇÏÁö¸¸ hemolysis ds´Â 10%¿¡¼¸¸ ¹ß»ý ÇÑ´Ù
; *usually
the infant are of type A1
; *prior
immunizationÀÌ ¾ø´õ¶óµµ
¹ß»ýÇÒ ¼ö
ÀÖ´Ù.
-
due to *univalent imcomplete(albumin
active) Ab
/
*7S (IgG) fractionÀ¸·Î cross placenta
- cf) natural AbÀÎ 19S (IgM) fractionÀº no cross placenta
Clinical Manifestation
; *most
mild, only jaundice
- ÀϹÝÀûÀ¸·Î ž ´ç½Ã¿¡ ¿µÇâÀ» ¹ÞÁö ¾Ê´Â´Ù
; hydrops fetalis is extremly rare
; jaundice´Â »ýÈÄ 24½Ã°£ À̳»¿¡ ³ªÅ¸³´Ù
Diagnosis
; direct Coombs test - weakly positive
; spherocyte
- Hb ; normal or 10-12g/dl
- reti ; 10-15%
- polychromasia, nucleated RBC
Treatment
; phototherapy
; ¡Úexchange
transfusion with blood of the same group as that of the mother
- Rh type should match the infants
Other form of Hemolytic ds
- <5%
- direct Coombs test ; positive
- anti-Kell Ab (hemolytic ds or anemia)
(erythroid suppression ¡æ anemia)
- congenital infection ; cytomegalic inclusion ds, toxoplasmosis, rubella, syphilis
hemolytic anemia, jaundice, hepatosplenomegaly,
thrombocytopenia
direct Coombs test - negative
- homozygous -thalassemia ; severe hemolytic anemia resembling hydrops fetalis
direct Coombs test - negative
- hereditary spherocytosis ; anemia, jaundice
89.3 Plethora in the Newborn (polycythemia)
; Hct ¡Ã 65%
# ¡Ø82,87 Increased incidence
; high altitude
;
*postmature
; SGA
; during first day of life (peak 2-3hr)
; in the recipient infant of a twin-twin transfusion
; after delayed clamping of the umbilical cord
; infants of diabetic mother
; 13-, 18-, 21-trisomy
; *adrenogenital synd
; *neonatal Graves ds.
; *hypothyroidism
; *Beckwith-wiedemann syndrome
Clinical Manifestation
- anorexia, lethargy, seizure, cyanosis(PFC), tachypnea, respiratory distress,
feeding disturbance, NEC, hyperbilirubinemia, renal failure, hypoglycemia,
thrombocytopenia
Treatment
; phlebotomy & replacement with saline or albumin
; ¡Ø91 Partial Exchange Transfusion
- *Hct to 50%
observed - desired Hct
volume of exchange(ml) = blood volume ¡¿ --------------------------
observed Hct
Long Term Prognosis
- speech deficit, abnormal fine motor control, reduced IQ
89.4 Hemorrhage in the Newborn infant
Hemorrhagic Ds Of The Newborn
; ¡Ø96 moderate decrease of Factor II, VII, IX, X in all newborn
by 48-72hr after birth
- gradual return by 7-10days
-
¡Ø96 ÀÌÀ¯
/
*lack of free vitamin K in the
mother, absence of bacterial intestinal flora
/ breast milk is a poor source of vitamin K
# Classification
;
*early onset(birth-24hr)
- mother treated with Pb, phenytoin
/ interfere with vitamin K function
; late onset (>1wk)
- vitamin K malabsorption : neonatal hepatitis, biliary atresia
# Clinical Manifestation
;
*GI, nasal, subgaleal,
intracranial, circumcision½Ã¿¡ bleeding
; prolonged PT, PTT, CT
# vitamin K facilitate post-transcriptional carboxylation of factor II, VII, IX, X
;
*ÀÌ·¯ÇÑ factor°¡ carboxylationÀÌ
¾ÊµÉ°æ¿ì PIVKA(protein induced
in vitamin K absence)¸¦ Çü¼ºÇÑ´Ù
# Prevention
; *1mg of natural oil-soluble vitamin K im(phylloquinone) at birth
Other Form Of Bleeding
; hematoma, melena, postcircumcision, umbilical cord
¡¤factor VIII, IX deficiencyÀÇ 5-35%¸¸ÀÌ newborn period¶§ ³ªÅ¸³´Ù
# ¡Ø90 APT test
;
*fetal Hb - alkali-resistant
; adult Hb - changed to alkaline hepatin
Chapter 90. Genitourinary System
Chapter 91. The Umbilicus
Umbilical Cord
- cordÀÇ ±¸¼º ; two umbilical artery, one vein
rudimentary allantois, remnant of omphalomesenteric duct
gelatinous substance (Wharton jelly)
- umbilical cordÀÇ sheath´Â amnion¿¡¼ ºñ·Ô ´Ù
- abnormally short cord ; fetal hypotonia
- long cord ; true knots or wrapping around fetal part
- straight unwristed cord ; fetal distress, anomaly, intrauterine fetal demise
- blood vessel ; functionally closed patent anatomically for 10-20 days
- artery ¡æ lateral umbilical ligament,
vein ¡æ ligamentum teres, ductus venosus, ligamentum venosum
# ¡Údelayed
separation of the cord (1°³¿ù ÀÌ»ó)
; neutrophil chemotactic defect
; overwhelming bacterial infection
# a single umbilical artery
; 5-10/1000 births, 35-70/1000 twin births
; 1/3 - congenital anomaly
; 18-trisomy
Patent Of The Omphalomesenteric (Vitelline Duct)
; intestinal fistula, prolapse of bowel, polyp(cyst), Meckel diverticulum
Persistent Urachus(Urachal Cyst)
; failure of closure of the allantoic duct
Congenital Omphalocele
- the sac is covered with peritoneum without overlying skin
- herniation of intestine ; 1/5000
- herniation of liver and intestine ; 1/10000
- immediate surgical repair ; before infection, before the tissues have been
damaged by drying or by rupture of the sac
- Beckwith synd ; omphalocele, macrosomia, hypoglycemia
Tumor
; angioma, enteroteraroma, dermoid cyst, myxosarcoma, cyst of urachal or
omphalomesenteric duct remnant
Hemorrhage
- due to trauma, inadequate ligation of the cord, failure of normal thrombus
formation hemorrhagic ds. of newborn, septicemia, local infection
Granuloma
; persistence of exuberant granulation tissue at the base of the umbilicus
# Pathogenesis
; presence of saprophytic organisms
--> delays separation of the cord & increase possibility of invasion by pathogenic organisms
--> mild infection
--> moist granulating area at base
# Clinical Manifestation
;
soft, vascular, granular, dull red or pink, *seropurulent
secretion
# Treatment
; cauterization with silver nitrate
-repeated at intervals of several days until the base is dry
# DDx
; umbilical polyp
- persistence of all or part of omphalomesenteric duct or of urachus
- firm and resistent, bright red, mucoid secretion
- Treatment
/ surgical excision
Infection
- hematogenous spread or extension to the liver or peritoneumÀÇ À§Ç輺ÀÌ ÀÖ´Ù
- septicemia ³ª hepatitis°¡ ÀÖÀ»Áö¶óµµ ³ªÅ¸³ª´Â Çö»óÀº minimal(periumbilical
erythema)ÀÏ ¼ö ÀÖ´Ù.
- Tx ; antibacterial therapy,
if abscess, I&D
Umbilical hernia
- due to an imperfect closure or weakness of the umbilical ring
- common especially in low birth weight, female, black infant
- covered by skin
- consist of omentum or portions of small intestine
Treatment
; mostly apear before 6mo and then disappear spontaneouly by 1yr
´ëºÎºÐÀº »ýÈÄ 1¼¼¶§ ÀúÀý·Î »ç¶óÁø´Ù
-
*large hernia(5-6cm)ÀÎ
°æ¿ì 5-6¼¼¶§
ÀúÀý·Î »ç¶óÁø´Ù
¡¤strapping is ineffective, surgery is not advised
;
¡Ø¢¾84
Surgical Indication
- persist to age of 3-4yr
- symptoms as strangulation
- larger after age of 1-2yr
;
*2cm ÀÌ»óÀÇ defect°¡ ÀÖÀ»
°æ¿ì ÀúÀý·Î
´ÝÈú °¡´É¼ºÀÌ
Àû´Ù.
Chapter 92. Methbolic Disturbances
Hyperthermia In The Newborn
(transitory fever of the newborn, dehydration fever)
- 38-39¡É, 2nd - 3rd day of life
- breast-fed infant, high environmental temperature
- the rise in temperature may be associated with an increase in serum protein,
sodium and hematocrit
- more severe form of neonatal hyperthermia
¡¤diminished sweating capacity
¡¤41-44¡É
¡¤the skin is hot & dry, flushed & apathetic, stupor, grayish pallor, coma,
convulsion, hypernatremia, convulsion
Neonatal cold injury
Clinical Manifestation
;
*apathy, refusal of food,
oliguria, coldness to touch
; BT ; 29.5 - 35
; immobility, edema, redness of the extremity
; bradycardia & apnea
; rhinitis
- common
- as are serious metabolic disturbance
/
*hypogycemia, acidosis
; hemorrhagic manifestation(massive pulmonary hemorrhage)
Treatment
; warming, correcting hypotension, metabolic imbalance
; *mortality rate 25%
; *»ýÁ¸ÀÚÀÇ 10% brain damage
Edema
- generalized edema ; hydrops fetalis, offspring of diabetic mother
- in premature ; decreased ability to excrete water or sodium
- HMD infant¿¡¼ CHF¾øÀÌ edema °üÂûµÉ ¼ö ÀÖ´Ù
- face & scalp edema ; umbilical cord¿¡ ÀÇÇØ neckÀÌ ´·ÈÀ»¶§
- hand or feet edema ; intrauterine pressure
- heart failure
- high-protein formula ; excessive solute load¿¡ ÀÇÇØ¼ edema¹ß»ý
- anemia, vit E deficiencyÀÏ ¶§µµ
- idiopathic hypoproteinemia ; ¸î ÁÖ¿¡¼ ¸î ´Þ Áö¼ÓµÇ´Âµ¥ ¿øÀÎÀº ºÒºÐ¸íÇϰí benign
ÇÏ´Ù
# persistent edema of one or more extremities
; congenital lymphedema(Milroy ds.) in female, Turner synd
# general edema with hypoproteinemia
; congenital nephrosis, Hurler synd.
after feeding hypoallergenic formulas to infant with cystic fibrosis of the
pancreas
Hypocalcemia(=Tetany)
- osteopenia of prematurity
- very small premature infants with chronic illness
- rickets-like synd. (pathologic fracture, demineralized bone)
- cholestasis, vit D or calcium malabsorption
urine Ca loss, poor calcium, phosphorus vit D intake
Hypomagnesemia
; unknown etiology but usually in association with hypocalcemia
; ¡ÚAsso.
Condition
- insufficient stores of skeletal Mg secondary to deficient placental transfer
- decreased intestinal absorption
- neonatal hypoparathyroidism
- hyperphosphatemia
- renal loss
- defect in Mg & Ca homeostasis
- iatrogenic
/
*exchange transfusion, TPN
- *DM mother
Clinical Manifestation
; indistinguishable from hypocalcemia & tetany
; < 1.5mg/dl
-
*but clinical signÀº 1.2mg/dlÀÌÇÏÀÏ °æ¿ì¿¡
´ëºÎºÐ ¹ß»ýÇÑ´Ù.
Treatment
; *MgSO4
IM
- *newborn 0.25ml/kg of 50% solution daily
- hypomagnesemia°¡ ±³Á¤µÉ ¶§ hypocalcemiaµµ ±³Á¤µÈ´Ù.
; oral maintenence therapy
; 1-2ÁÖÈÄ d/c
Hypermagnesemia
Etiology
; eclampsia mother¿¡¼ MgSO4·Î Ä¡·á¹Þ¾ÒÀ» °æ¿ì¿¡ ¹ß»ýÇÑ´Ù.
Clinical Manifestation
; CNS depression, totally paralyzed
; hypoventilation, hypotension, lethargy, flaccidity, hyporeflexia
; normalÀÇ upper limit ; 2.8mg/dl
; serious symptom ; >5mg/dl
; failure to pass meconium(Meconium plug synd)
Treatment
; exchange transfusion
; calcium salt & diruresis
Substance Abuse And Withdrawals
- opiates cross placenta
- heroin, methadone, alcohol, Pb, pentazocine, codeine, propoxyphene, diazepam ;
withdrawal symptom
Heroin Addiction
; 50%¿¡¼ low birth weight infant
- 1/2˼ SGA
; the rate of still births is increased,
but *not the incidence of congenital
anomalies
Clinical Manifestation
; 50-75% 48½Ã°£À̳»¿¡ ³ªÅ¸³²
; *tremor
& hyperirritability
-
*¡ãprominent symptoms
- *Tremor : hypoglycemia¿¡ ÀÇÇÑ
°æ¿ì¿¡ ±¸º°ÀÌ
Èûµé´Ù. ±×·¯³ª more coarse, flapping, bilateral ·Î
±¸ºÐÀÌ °¡´ÉÇÏ´Ù.
;
other symptoms
- tachypnea, diarrhea, vomiting, high pitched cry, fist sucking, poor feeding, fever
-
less commonly sneezing, yawning, myoclonic jerks, convulsions, abnormal sleep
cycles, nasal stuffiness, flushing alternating rapidly with pallor, lacrimation
; ¡Ø°´ HMD, hyperbilirubinemiaÀÇ incidence´Â
°¨¼ÒÇÔ
- HMD°¨¼ÒÇÏ´Â ÀÌÀ¯
/ hyperventilation --> production of surfactant
- hyperbilirubinemia °¨¼ÒÇÏ´Â ÀÌÀ¯
/ induction of glucuronyl transferase
Methadone Addiction
¡¤severe withdrawal symptom
¡¤20-90%
¡¤no increased incidence of congenital anomaly
¡¤clinical manifestation ; higher incidence of seizure(10-20%)
late onset (2-6wk of age) of symptom & sign
Alcohol Withdrawal
¡¤uncommon
¡¤hypogycemia, acidosis, seizure
Phenobarbital Withdrawal
¡¤symptom ; 7ÀÏÈÄ¿¡ ½ÃÀÛ
¡¤acute stage ; irritability, constant crying, sleeplessness, hiccups, mouthing
movement
¡¤subacute stage(2-4°³¿ù°£) ; voracious appetite, frequent regurgitation &
gagging, episodic irritability, hyperacusis,
sweating, disturbed sleep
Cocaine Addiction
¡¤premature labor, abruptio placenta, fetal asphyxia
¡¤IUGR, microcephaly, ICH, possible anomaly of the GI & renal tract
¡¤SIDS
¡¤rigidity, impaired state regulation, developmental delay, learning disability
Treatment
; indication
- seizure, diarrhea, irritability, poor weight gain
- Treatment of heroin & methadone with drawals has been successful using
various combination of narcotics, sedative, hypnotics
; *Pb
8-10mg/kg/24hr in 4 divided dose
- chlorpromazine, 2.2mg/kg/24hr, 3-4 dose
- Patients with severe autonomic symptom may require gradually diminishing
doses of methadone or paregoric for 2-10wk
- narcotic & Pb withdrawal requires swaddling frequent feedings, and protection
from noxious external stimuli
Fetal Alcohol Syndrome
; moderate & high alcohol intake during pregnancy
--> damage to embryonic and fetal fetal development
--> specific malformation
# ¡Ø90ÁÖ
Characteristics
; prenatal onset and persistence of growth deficiency for length, weight, head circumference
; facial abnormality
- short palpebral fissure, epicanthal folds, maxillary hypoplasia, micrognathia, thin upper lip
; cardiac defects, primary septal defect
; minor joint and limb abnormality
- some restriction of movement and altered palmar crease patterns
; delayed development and mental deficiency
- from borderline to severe
# common cause of mental retardation
# alcohol may impair placental transfer of essential aminoacid & zinc
Late Metabolic Acidosis
; 5-10% of preterm low birthweight infant
; *acidosis
during the 2nd or 3rd wk of life
; *no
history of asphyxia, respiratory distress or other problem
Etiology
; cow's milk formulas of high protein and casein content shortly after birth
; abnormally high rate of endogenous acid formation
Treatment
; NaHCO3
; formula of lower protein content with a whey ; casein ratio of 60:40
Chaper 93. The Endocrine System
Pituitary Dwarfism
; not apparent at birth
; panhypopituitary male infant
- neonatal hypogycemia, micropenis
Thyroid Deficiency
; apparent at birth
; constipation, prolonged jaundice, lethargy, poor peripheral circulation(mottled skin)
Temporary Hyperthyroidism
; occur at birth
; mother with hyperthyroidism receiving thyroid medication
Transient Hypoparathyroidism
; tetany of the newborn
Adrenal Gland
; acute adrenal hemorrhage & failure (breech or other traumatic delivery)
; adrenocortical hyperplasia (vomiting, diarrhea, dehydration, hyperkalemia, hyponatremia, shock, clitoral enlargement)
Congenitally Hypoplastic Adrenal Gland
; adrenal insufficiency during the first few weeks of life
Transient Diabetes Mellitus
; rare, seen only in the newborn
; dehydration, loss of weight, acidosis in SGA
93.1 Infant Of Diabetic Mother
# ¡Ø92 morphologic characteristics(large size , macrosomia)
& high mobidity risk
# mother
;
*polyhydramnios, pre-eclampsia,
pyelonephritis, preterm labor, chronic hypertension
# fetal mortality rate
;
*greater than 32wks
# *»ê¸ð¿¡°Ô vascular ds°¡ ÇÕº´µÇ¾úÀ»
¶§´Â low birth weight
infant°¡ žÙ
# mortality rate ; 5¹è
Pathophysiology
# fetal hyperglycemia, fetal hyperinsulinemia
¡æ hepatic glucose uptake & glycogen synthesis ¡è
¡æ lipogenesis, protein synthesis ¡è
# hypertropy and hyperplasia of the pancreatic islet
# increased weights of the placenta and infant organs except brain
; myocardial hypertropy, increased amount of cytoplasm in liver cell, extramedullary hematopoiesis
# hyperinsulinism ¡æ fetal acidosis ¡æ still birth
# ¢¾Cause
Of Hypoglycemia
1) ž¸é¼ placenta°¡ ºÐ¸®µÇ¸é glucose infusionÀÌ °©ÀÚ±â ÁߴܵȴÙ. ±×·¯³ª žƿ¡°Ô´Â hyperinsulinismÀÌ ¾ÆÁ÷ Á¸ÀçÇϰí ÀÖ´Â »óÅÂÀ̹ǷΠhypoglycemia°¡ ¹ß»ýÇÑ´Ù
2) diminished epinephrine & glucagon ¡æ hypoglycemia
# congenital anomaly ; hyperglycemia-induced teratogenesis
Clinical Manifestation
; large & plump
- result of increased body fat, enlarged viscera with puffy, plethoric face
; *»ýÈÄ 3ÀÏ µ¿¾ÈÀº jumpy, tremulous, hyperexcitable
- hypotonia, lethargy, poor suckingÀÌ ¿Ã ¼öµµ ÀÖ´Ù
; early hypoglycemia, later hypocalcemia
; hypoglycemia
-
*diabetic motherÀÇ 75%
- *gestational diabetesÀÇ 25%
- À̵éÁß
small percentage¸¸ symptomatic
-
*1-3hr¿¡ blood glucose levelÀÌ ÃÖÀú, 4-6hrÈĺÎÅÍ spontaneous recovery
; ¢¾Tachypnea
During The First 5 Days Of Life
- due to hypoglycemia, hypothermia, polycythemia, cardiac failure, transient tachynea, cerebral edema from birth trauma or asphyxia
; *RDS ¡è
-
*due to antagonistic effect of
cortisol, insulin against synthesis of surfactant
; cardiomegaly(30%), heart failure(5-10%), asymmetric septal hypertropy
; neurologic development & ossification center
-immature
; increased incidence of hyperbilirubinemia, polycythemia, renal vein thrombosis
; ¡ØCongenital Anomaly - 3¹è
- cardiac malformation
/ VSD, ASD, COA, transposition of great vessel
- lumbosacral agenesis
- neural tube defect
- hydronephrosis, renal agenesis
- duodenal, anorectal atresis
- holoprosencephaly
- small left colon syndrome
-
*cardiac malformation°ú lumbosacral agenesis°¡ °¡Àå
ÈçÇÔ
Prognosis
; the subsequent incidence of DM in infant is increased
Treatment
# asymptomatic infant
; blood sugar¸¦ »ýÈÄ 1½Ã°£ À̳»¿¡ checkÇÏ¿© 6-8hr µ¿¾È ¸Å½Ã°£¸¶´Ù checkÇÑ´Ù
# if clinically well & normoglycemic
; 5% glucoseÀÇ oral feeding ¡æ breast milk or formula
; »ýÈÄ 2-3½Ã°£¿¡ ½ÃÀÛ, 3½Ã°£ interval·Î °è¼ÓÇÔ
# *bolus
injection of hypertonic glucose should be avoided
; because they may cause further hyperinsulinemia ¡æ rebound hypoglycemia
93.2 Hypoglycemia
; early feeding
- incidence¸¦ °¨¼Ò½ÃŲ´Ù
# ¡Ø89 Increased Incidence
- prematurity, hypothermia, hypoxia, maternal diabetes, maternal glucose infusion in labor, IUGR
# ¡ÚGlucose
Level In Healthy Term Infant
- decline after birth untill 1-3hr
-
rarely less than *35 mg/dl between 1-3hr
-
rarely less than *40mg/dl between 3-24hr
-
rarely less than *45mg/dl after 24hr
# ¢Þ89,96 Four Pathophysiologic Group At High Risk Of Developing
Hypoglycemia
*1) Hyperinsulinism Group
;
mother DM, gestational DM, severe erythroblastosis fetalis, insulinoma, ¥â cell nesiodioblastosis, functional
¥â cell
hyperplasia, mutation in sulfonylurea receptor gene, *Beckwith syndrome, panhypopituitarism
*2) Intrauterine Malnutrition Group
; resulting in reduced hepatic glycogen store & total body fat(IUGR, preterm)
; smaller of discordant twin, polycythemic infant, toxemic mother placenta abnromality
; other factors
- impaired gluconeogenesis, diminished free fatty acid oxidtion, low cortisol production rates, increased insulin level & decreased output of epinephrine in response to hypoglycemia
*3) Very Immature or Severely Ill Infant Group
; increased metabolic need
; low birth weight infant with RDS, perinatal aspyxia, *polycythemia, hypothermia, systemic infection, heart failure with cyanotic congenital heart disease
*4) Genetic or Primary Metabolic Defect Group
; galactosemia, glycogen storage ds., fructose intolerence, propionic acidemia, methylmalonic acidemia, tyrosinemia, maple syrup urine ds, long or medium-chain acyl-CoA dehydrogenase deficiency
Clinical Manifestation
; symptomatic hypoglycemia - SGA¿¡¼ highest incidence
¡ÚFig.
93-2
; symptomÀÇ ´ëºÎºÐÀº ´Ù¸¥ condition°ú ÇÔ²² ³ªÅ¸³´Ù
- infection, CNS anomaly, hemorrhage, edema, hypocalcemia, hypomagnesemia, asphyxia, drug withdrawal, apnea of prematurity, CHD, polycythemia
; ¡Ø87 Order Of Frequency
- jitteriness or tremor, apathy, episodes of cyanosis, convulsion, intermittent apneic spell or tachypnea, weak or high pitched cry, limpness or lethargy, difficulty in feeding, eye rolling
; episodes of sweating, sudden pallor, hypothermia, cardiac arrest
¡Ø91 Treatment
; convulsionÀÌ ¾ø´Â °æ¿ì
- 10% glucose 200mg/kg(2ml/kg)
; convulsionÀÌ ÀÖ´Â °æ¿ì
- 4ml/kg of 10% glucose
# Following therapy after initial therapy
;
*glucose infusion - 8mg/kg/min
# ¡Ø87 20% glucoseÀ»
Á൵ ¹ÝÀÀÇÏÁö ¾Ê°Å³ª
À¯ÁöµÇÁö ¾Ê´Â °æ¿ì
;
*hydrocortisone 2.5mg/kg/6hr
;
*prednisone 1mg/kg/24hr
# ¡ÚSteroidÀ»
½áµµ ¹ÝÀÀÇÏÁö
¾Ê´Â °æ¿ì
; diazoxide or long-acting somatostatine
# Monitoring
; initial therapy ÈÄ serum glucose¸¦ 2½Ã°£¸¶´Ù checkÇÏ¿© 40mg/dlÀÌ»óÀÌ µÇ°Ô ÇÑ´Ù
; ÀÌÈķδ 4-6½Ã°£¸¶´Ù
;
*high risk infantÀÇ
°æ¿ì
- Ãâ»ý 1½Ã°£À̳»¿¡ serum glucose
-
*óÀ½ 6-8½Ã°£±îÁö´Â 2½Ã°£
°£°Ý
- 24½Ã°£±îÁö´Â 4-6½Ã°£ °£°Ý
# nesioblastosis & islet cell adenoma
; surgery
; glucagon + somatostatin
# intravenous infusion of glucose at 4mg/kg/min should be provided if oral feeding are poorly tolerated or if asymptomatic transient neonatal hypoglycemia develops.
Prognosis
; recur in 10-15%
Hypoglycemia With Macroglossia(Beckwith Synd)
; intractable neonatal hypoglycemia, macroglossia, large size, visceromegaly(liver, kidney), mild microcephaly, omphalocele, facial nevus flammeus, charicteristic earlobe crease
; increased risk of tumor( Wilm's tumor, hepatoblastoma, gonadoblastoma) and renal medullary dysplasia
; polycythemic, hyperinsulinemia
; partial duplication of chromosome IIp (insulin like growth factor II gene)
; prognosis is poor